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Abstract 
The present studies describe our recent work on expanding the use of the Burgess 
reagent and its reaction with oxiranes. Several new variants of the Burgess reagent and its 
chiral auxiliary version were evaluated for their thermal stability by NMR spectroscopy. 
Three new versions of the reagent were synthesized and their stability was determined. 
The reactivity of all five Burgess reagents was compared in a dehydration reaction and 
reactions with epoxides and diols. 
Progress toward a chemoenzymatic synthesis of morphine is also included in this 
report. The synthesis began with the whole cell oxidation of bromobenzene by 
Escherichia coli JMI09(pDTG601). The preparation of several precursors for a key step 
involving the lohnson-Claisen rearrangement and progress toward the total synthesis are 
described. 
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I. Introduction 
This thesis is presented in two parts. In the first part, the design of new variants of 
type 2 of the Burgess reagent 1 and their thermal stability is to be investigated. The 
second part is concerned with progress toward the total synthesis of morphine 3 with the 
key steps being biooxidation of bromobenzene 4 and a Claisen rearrangement to set the 
C-13 quaternary center. 
The Burgess reagent 1 is a useful tool for performing a variety of transformations 
in organic synthesis. However, it is unstable at high temperatures and in the presence of 
acids. We investigate new variants of the reagent to overcome this instability and then 
evaluate the stability and reactivity by NMR techniques. The methoxy portion of the 
carbamate will be replaced with the more electron withdrawing 2,2,2-trifluoroethanol to 
better stabilize the negative charge. The triethylamine portion will be replaced with the 
more electron donating N-methylpiperidine to stabilize the positive charge (Figure 1). 
EDG EWG 
2 
Figure i-Design of new Burgess reagents 
Morphine (3) is a commonly used analgesic with a complex structure. Its use by 
mankind has spanned centuries. Our proposed synthetic route, shown in Figure 2, begins 
with the dihydroxylation of bromobenzene (13) with Escherichia coli JM109 
(pDTG601). Reduction of the distal double bond and coupling with Boc glycine will 
provide 11 which will be subjected to a Kazmaier-Claisen rearrangement. Subsequent 
methylation and separation of the diastereomers will give the C-ring fragment 9 which is 
to be coupled to A-ring fragment 8. The coupled intermediate will be further elaborated 
- 1 -
to the substrate for the second Claisen rearrangement 6. Subsequent closure of the B- and 
D-rings and further elaboration should provide morphine (Figure 2). 
Connected to the biooxidation of bromobenzene (13) to diol 12 was the 
investigation of several halogen substituted benzoate esters that were tested as substrates 
for the enzyme toluene dioxygenase (TDO). The yields and physical and spectral 
properties of the new metabolites will be presented. 
Br C02Me Br C02Me /o~ .~ NHBoc <~~ === .~NHBOC + 'O~ <~~ === 
TDSO" V TDSO" V B(OHh 
10 9 8 
I 
B 0 cxo~NHB" 
11 OTDS 
--""",> LOH 
UOH 
12 
----;I> 6 
13 
Figure 2-Retrosynthetic analysis for morphine 
- 2-
2. Historical 
2.1 Burgess reagent 
2.1.1 Development of Burgess reagent and dehydration reactions 
The fIrst reported synthesis of an alkyl N-(triethylammoniumsulfonyl)carbamate 
inner salt was in 1968 when Edward Burgess and George Atkins studied the reactivity of 
N-sulfonylamines. 1 Inner salt 15 was an intermediate that was subjected to fragmentation 
to prepare N-sulfonylamine 16 (Figure 3). 
0" ,9 ~ 
Et3N ... 
S
'N ............. O./'-...... 
(±) e 
15 
Figure 3-Burgess' sulfonylamine preparation 
+ 
16 
In their previous work 16 was generated in-situ by treating 14 with one equivalent 
of triethylamine and intercepting the unstable sulfonylamine with a nucleophile such as 
aniline (17).1 The more reactive benzoyl sulfonylamine 19 was also generated in the 
presence of ethyl-vinyl ether (21) to form cycloadduct 22 (Figure 4). 
0 
-78°C Et3N 0 Qo 0 0 0" ~O )l 0, )l H2NPh (17) Cr· ... S'N O~ .. 'S=N O~ ~ N~S~N)lO~ 
- Et3NHCI " 
.. 
H 0 H H 
14 16 18 
0 0 ~O~ o 0 o"p~ -78°C Et3N 0, ~ o~g ~ Cr ... ·S'N ~ .. ~S=N I: 21 q I: H 1 b - Et3NHCI .. 
OEt 
19 20 22 
Figure 4-Generation of N-sulfonylamines l 
Burgess and Atkins reported several electrophilic additions to 15 (Figure 5).2 The 
reaction of 15 with aniline gave 17 in 92 % yield. The addition of N-vinylpyrrolidinone 
- 3 -
(23) to 15 gave 24 in 50 % yield and the addition of isopropanol to 15 gave 26 in low 
yield. 
o 0 0 .... II II o~~SY"OEI 
OH 
A 
25 
V 24 
Figure 5-Electrophilic addition to N-(triethylammoniumsulfonyl)carbamate inner salf 
In 1970, Burgess prepared the methyl variant of the inner salt 1, which would 
later be named the Burgess reagent. This compound was found to be a very mild 
dehydrating agent for secondary and tertiary alcohols (Figure 6).3 
OH 
A ~ 
25 .. 27 
0 b OH d? O~-,/O )l Et N ... S .... N 0/ 28 
3Et:) e .. 29 
1 
>r0H A 30 
.. 31 
Figure 6-Dehydration reactions of secondary and tertiary alcohols with Burgess reagene 
When primary alcohols were treated with the Burgess reagent, dehydration did 
not occur. Instead, primary urethane 32 was formed via an SN2 pathway (Figure 7).3 
-4-
n-hexanol 
90% 
o 
~N)lO/ 
32 H 
Figure 7-Reaction of Burgess reagent with n-hexanoe 
Depending on reaction conditions, allylic alcohols were shown to either undergo 
dehydration reactions or form urethanes via an SN2 pathway rearrangement (Figure 8).3 
~ 
35,70 % 
triglyme 
OIl( 
+ 
1 
OH 
~ 
33 
1. neat, 80 DC ,. 
36, >90 % 
Figure 8-Formation of diene or urethane from an allylic alcohol with Burgess reagene 
In the 1970 full paper, isotope studies were presented that showed that the 
elimination of an alcohol by 1 was a syn-elimination.3 Erythro and threo-2 deutero-l,2-
diphenyl ethanol (37 and 38 respectively) were treated with Burgess reagent. The former 
yielded only trans-stilbene (39) while the latter yielded only protio-trans-stilbene (40). 
The rate limiting step was shown to be the formation of an ion pair 42 followed by a fast 
cis-p-proton transfer (Figure 9). 
- 5 -
O}- / O}- / 
° 0 
o 0 
O~s-Ne O~s-Ne H Ph HO 0 1 slow eq ) fast 
prH H'H"Ph 
I )Do )Do )Do 0 0 (!) H'H"Ph " 0 Ph H 
-
Et3NH f£< 37 Ph H H'" "'Ph 39 
41 Ph H 
42 
H Ph 
HO H 1 
pro '''H''Ph )Do (!) Ph 0 
-
Et3NH 
38 40 
Figure 9-Mechanism of dehydration by the Burgess reagent 
When the carbocation intermediate in a dehydration reaction is highly stabilized, 
rearrangements can occur thus making olefin formation less predictable, as in the case of 
46 (Figure 10).3 
00H 1 ~ ~ )0 
43 44 (2.4) 45 (1) 
>f-H 1 ~ )0-
46 47 
-j-{H 1 h >=< H )0-
49 (1) 50 (3) 51 (1.5) 
48 
Figure 10-Dehydration of alcohols with stabilized carbocation intermediates (product ratio) 
Following Burgess' work on dehydration reactions with 1, several other reactions 
were reported. In 1988, Claremon and Phillips reported the dehydration of primary 
amides to nitriles with the Burgess reagent (Figure 11).4 
- 6-
o 0 
0 OH [ O~S'-N)lo/] 
R)lNH2 
"'" 
RANH 
1 LO G) ... 
.. A"H R N' 
-----l .. ~ R-C=N 
52 53 54 55 
Figure ll-Dehydration of amides to nitriles with the Burgess reagent4 
Prathapan and co-workers reported the synthesis of nitriles from cis-aldoximes 
with the Burgess reagent in 2000 (Figure 12).5 
H 
~N,OH 
U 
56 
1,3 eq . 
... 
58,66 % 
Figure 12-Conversion of cis-aldoximes to nitriles with the Burgess reagentS 
McCarthy and co workers used the Burgess reagent to convert formamides to 
isocyanides (Figure 13).6 
59 
1, 1.5 eq 
... 
DCM, reflux 
60,80 % 
Figure 13-Synthesis of isocyanides from formamides6 
Building on the work of Claremon, Barvian and co-workers used the Burgess 
reagent to dehydrate ureas to carbodiimides in up to 91 % yield. These reactions were 
often clean enough not to require chromatography of the products (Figure 14).7 
- 7 -
1,2.1 eq 
DCM, rt, 20 hrs 
Ph_N=C=N~OMe 
~OMe 
62,91 % 
Figure 14-Barvian's preparation of carbodiimides from ureas7 
As part of a research project on milder conditions for the dehydration of primary 
nitroalkanes, Mioskowski and co-workers reported that the Burgess reagent worked 
under mild conditions (Figure 15).8 However, they found diethylaminosulfur trifluoride 
(DAST) to be the best reagent for the dehydration of nitroalkanes. 
3 eq. 1, 5 eq Et3N 
• PhMe, 50 DC 
~C~~e V 0 ~nC4H9 ~nC4H9 ----~~~ V N-d 
64 65 
Figure 15-Dehydration of nitroalkanes with Burgess reagent8 
Burgess dehydrations are often milder than standard acid catalyzed dehydrations. 
Often, the Burgess reagent can effect a dehydration at temperatures lower than 70 DC. 
2.1.2 Alternative reactions of the Burgess reagent 
Since the 1990s reactions employing the Burgess reagent have been greatly 
expanded to include cyclodehydration reactions and non-dehydration reactions including 
the formation of heterocycles and various functional group interconversions. 
Wipf and co-workers employed the Burgess reagent in a cyclodehydration 
reaction. ~-Hydroxy-a-amino acids of type 66 were treated with Burgess reagent (1) to 
yield 4,5-dihydrooxazolines 68 (Figure 16).9 When Mitsunobu conditions were used for 
this reaction, there were often side products, such as aziridines, formed. to 
- 8 -
1, THF 
lit 
66 
j 
DCM, DoC 
69 70 
Figure 16-Cyclodehydration of P-hydroxy-a-amino acids with the Burgess reagent9 
Wipf also applied this methodology to the formation of thiazoline peptide analogs 
(Figure 17) .11 The Burgess reagent gave the desired thiazolines in 96 % yield with 97:3 dr 
in about 10 minutes. The same reaction under other conditions, such as TsClIEt3N, 
SOClz/pyridine or Mitsunobu conditions, was lower yielding and led to extensive 
epimerization at the C-2 position. 
- 9-
+ 
72 
Conditions Yield [%J Ratio 72:73 
TsCI, Et3N, DCM, 42°C, 1 hr 40 1 :1 
1. SOCI2, 0 °C, 2 hr; 2. pyridine, THF, O°C, 15 min 49 1: 1 
Ph3P, DIAD, DCM, -78 to 22°C, 30 min 80 78:22 
Burgess reagent (1), THF, 65°C, 10 min 96 >97:3 
Figure 17-Fonnation ofthiazoline rings under various conditionsll 
Li employed the Burgess reagent as a cyclodehydration agent in the preparation of 
a series of N-bridged 5,6-bicylic pyridines. 12 
The Nicolaou group employed the Burgess reagent in the synthesis of several 
sulfone containing heterocycles.13 In 2002, Nicolaou and co workers reported that the 
Burgess reagent could be used to synthesize sulfamidates from chiral 1,2 diols with 
excellent regio- and stereoselectivity.14 The diols were prepared from styrene by the 
Sharpless asymmetric dihydroxylation and then treated with excess Burgess reagent 
yielding the cyclic sulfamidates. The sulfamidates were then hydrolyzed under acidic 
conditions to yield p-amino alcohols (Figure 18). The minor product was originally 
assumed to be regioisomer 76 but was later proven to be misassigned (See pages 15-16 
for discussion ofthe structure correction). 
- 10-
OH 
~OH 
V 
2.5 eq 1, THF 
reflux,1 hr 
74 
o 
" II 0 O~ 15 -0 N- -
- \ ~ 0 
V 
o 
110 0-5-:::' 
- \ 0 
+ ~ N-f VO-
75 major 76 minor (assumed structure) 
I Hel, 4 M I Hel, 4 M t H20:dioxane (1 : 1) t H20:dioxane (1: 1 ) 
o 
'o..J< NH 
::- OH 
V 
77 78 
Figure IS-Formation of ~-amino alcohols from styrene derived diols14 
Nicolaou expanded on this methodology using the Burgess reagent to synthesize 
5,6, and 7-membered sulfamides from amino alcohols (Figure 19).15 
1 
79 
1 
81 
1 
83 84 
Figure 19-5ynthesis of sulfamides from amino alcohols15 
- 11 -
Nicolaou and co-workers applied their methodology to the synthesis of (l- and 
~-glycosylamines (Figure 20).16 The Burgess reagent was well suited to this chemistry 
because regio- and stereo selectivity are very predictable. For the preparation of (l-
glycosylamines 88, 3,4,6-protected sugars 85 were treated with the Burgess reagent. The 
resulting sulfamidate 87 was then subjected to nucleophilic attack. ~-Glycosylamines 92 
were prepared from 2,3,4,6-protected sugars 89. This reaction followed an SN2 pathway 
similar to Burgess' early disclosures. 
RO RO~-O OH RO~ 
OH 
85 
RO RO~-O OH RO~ 
OR 
89 
2.5 eq 1 
86 
2.5 eq 1 l R:~ -0 0_S~~-C02R] .,.. . <==~ 
-------...... RO~ II 0 
OR 0 
90 
Figure 20-Nicolaou's synthesis of (1- and ~-glycosylamines16 
While attempting the dehydration of the alcohol moiety in 93, Raghavan and co-
workers discovered that Burgess reagent reacts preferentially with sulfoxides to give 
sulfilimines 95 (Figure 21).17 Initial reactions carried out at 60°C in THF gave only 
- 12-
about 30 % yield. The reaction was optimized and was found to be high yielding when 
performed in benzene at room temperature. By varying the alkyl component of the 
Burgess reagent 98, Raghavan was able to prepare several sulfi1imines 97. 
e 
o 
I 
e 
o 
I 
e 
NC02Me I 
/~l P-TOl o 1, THF ... )( /~*c p-Tol l)H 1, THF /~*c p-Tol l)H 
94 93 
000 
"II II 
Et N .... S'N/'-OR 
3@ e 
98a-d 
PhH, rt 
a:R = Me 
b:R = Bn 
c:R = Allyl 
d:R = CH2CCI3 
e 
NC02R I 
R1-~'R2 
97 
Figure 21-Formation of sulfilimines from sulfoxides 17 
95 
Makara and co-workers treated a series of carboxylic acids with Burgess reagent 
to give mixed sulfcarboxyanhydrides of type 100 (Figure 22).18 The mixed anhydrides 
could then be treated with amines to form amides 101 or acyl ureas 103. Makara found 
that excess 1 was required with slow reactions due to decomposition of the Burgess 
reagent. The conversion of an acid to an amide or acyl urea could be completed in one 
pot as long as excess Burgess reagent was destroyed to prevent the formation of 
sulfamidates. This was accomplished by heating the reaction mixture to 80°C for 15 
minutes before the addition of the amine. The ratio of amide to acyl urea could be 
controlled by adjusting the temperature and employing microwaves as a heat source. 
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1.4 eq 1, MeCN, 
1.5 eq DIPEA 
5 min rt then 15 min 80 DC 
1
3.0 eq R2R3NH 
80 DC (f.lW) 
o 
R)lNR2R3 
101 
150 DC (f.lW), 8 min 
Figure 22-Preparation of acyl ureas and amides from carboxylic acids18 
Until 2001, it was believed that the Burgess reagent was inert to epoxides. In his 
review in 2000 Lamberth stated, "The compatibility of the Burgess reagent with many 
functionalities, e.g. halogens, epoxides, alkenes, alkynes, aldehydes, ketones, acetals, 
esters, secondary ami des, makes it an attractive technique for the introduction of C-C 
double bonds into highly functionalized molecules".19 However, in 2003 Hudlicky and 
co-workers showed that the Burgess reagent reacted with epoxides to form cyclic 
sulfamidates. Lamberth cannot be blamed for the statement however, because several 
dehydration reactions had been performed on molecules containing epoxides with 
dehydration taking place preferentially to sulfamidate formation.3,20 
In 2003, Hudlicky and co-workers showed that the Burgess reagent reacts with 
epoxides to form five or seven membered cyclic sulfamidates.21 It was discovered that 
aliphatic epoxides formed only five membered sulfamidates while benzylic epoxides 
formed mostly seven membered sulfamidates with five membered sulfamidates being 
produced in about 2 % (Figure 23). 
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Figure 23-Formation of 5- and 7-membered sulfamidates from epoxides21 
o 
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During subsequent work it was shown by Hudlicky that the five membered 
sulfamidate 105 which was initially thought to have a trans-stereochemistry was actually 
cis 109?2 A mechanism was proposed to account for the cis stereochemistry.22 
Hudlicky's proposed mechanism requires two equivalents of Burgess reagent and is 
similar to the mechanism Nicolaou proposed for the reaction of Burgess reagent with 
diols (Figure 24).14 
2 eq 1 
104 
109 
Figure 24-Hudlicky's proposed mechanism for the formation of cis-cyclic sulfamidates 
Hudlicky also noted that the seven membered sulfamidate 107 formed from 
styrene oxide (106) was spectroscopically identical to Nicolaou's minor product (76, 
page 11, Figure 18) in the reaction of Burgess reagent with styrene diol 74.14 An X-ray 
crystal structure was acquired which proved that Nicolaou's minor product was indeed 
seven membered sulfamidate 107.21 A mechanism with degenerate pathways that 
accounts for the formation of both five and seven membered sulfamidates was proposed. 
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- \ 0 ~N-L 
76, proposed structure 107, actual structure 
Figure 25-Correction of the structure of76 
In another case of unexpected reactivity, Hudlicky and co-workers showed that 
when treated with Burgess reagent, thiols form disulfides (Figure 26).23 Hudlicky had 
been attempting to expand the scope of Burgess dehydration and urethane formation to 
primary, secondary and tertiary thiols. However, when decane-l-thiol (104) was treated 
with Burgess reagent under standard conditions, disulfide 105 was isolated in nearly 
quantitative yield (Figure 26). 
(ySH 
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~SH 
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.. 
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)Ir 
CH3(CH2)gS-S(CH2)gCH3 
111 
~CI 
(ys'sN M CI 113 
115 
Figure 26-Forrnation of symmetrical disulfides from thiols23 
2.1.3 Variants of the Burgess reagent 
Several researchers have modified the alkyl or amine portions of the Burgess 
reagent for improved reaction characteristics or to incorporate different alkyl groups into 
their products. The Nicolaou group prepared variants of the Burgess .reagent with 
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different alkoxy groups 98a-e in their sulfamidate and sulfamide syntheses. 14-15 The 
methyl, benzyl, allyl, trichloroethyl, and o-nitro benzyl versions 98a-e were employed in 
the synthesis of sulfamidates and the methyl, benzyl and allyl versions 98a-c were used 
in sulfamide preparation. Raghavan employed Nicolaou's new Burgess reagents 98a-d in 
his preparation of sulfilimines from sulfoxides. 17 
a:R = Me 
b:R = Bn 
c:R = Allyl 
d:R = CH2CCI3 
e:R = o-N02Bn 
Figure 27-Burgess reagents utilized by Nicolaou 
Over the course of their studies of cyclodehydrations, the Wipf group noticed that 
the Burgess reagent decomposed upon exposure to moisture and oxidative conditions and 
that they obtained the best yields with freshly prepared Burgess reagent.24 To improve the 
stability of the reagent, ease of handling and ease of purification of the products, Wipf 
developed a poly(ethylene glycol) (PEG) (116) linked version of the Burgess reagent 118 
(Figure 28). They found that yields of oxazolines and thiazolines were 10-20 % higher 
when the PEG supported reagent was used in place of 1. Upon completion of the 
reaction, filtration through a plug of silica often led to pure product as unreacted 118 and 
by-products remained absorbed in the PEG matrix or on silica gel. 
Ho~~0o~OMe) 
y 
PEG 
116 
2.2 eq Et3N 
Figure 28-Wipfs preparation of PEG linked Burgess reagent 118 
Brain and co-workers employed Wipfs PEG supported Burgess reagenr4 in the 
synthesis of 1,3,4-oxadiazoles 120 from 1,2-diacylhydrazines 119 under microwave 
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conditions (Figure 29).25 Reaction times from two to four minutes under 100 W 
microwave conditions were noted. Building on Brain's work, Li and Dickson developed a 
one pot procedure for the synthesis of 1,3,4-oxadiazoles that proceeded in moderate to 
excellent yield at room temperature.26 
o 0 
R)lN-NAR2 
H H 
119 
118 
~LW, THF 
Figure 29-Brain's synthesis of 1,3,4-oxadiazoles with PEG supported Burgess reageneS 
While looking to develop a stable and efficient sulfamoylating reagent, Montero 
and co-workers developed reagent 121 (Figure 30).27 Montero had been using 
chlorosulfonyl isocyanate (117) as a sulfamoylating reagent but found it was often too 
reactive. In order to reduce the reactivity, they treated it with tert-butanol and then 
DMAP. This led to Burgess type reagent 121. Reagent 121 was shown to be an efficient 
sulfamoylating reagent giving products in moderate to high yields under mild conditions. 
Figure 30-Montero's sulfamoylating reagene7 
At the same time as Nicolaou was developing variants of the Burgess reagent for 
the formation of sulfamidates and sulfamides 14-15 the group of Wood independently 
developed the benzyl version of the Burgess reagent 98b for a one step conversion of 
primary alcohols to Cbz protected amines.28 
Masui and co-workers prepared a variant of the Burgess reagent by treating 117 
with isopropanol and pyridine in a one pot procedure?9 The reagent could then be treated 
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with dry or aqueous amines to form sulfamides (Figure 31). The advantage to Masui's 
methodology was that sulfamides could be produced from aqueous amines such as 
ammonia or methylamine at room temperature where traditional methods required 
anhydrous amines and low temperatures (either because of the low boiling point of the 
amine or exothermic reactions). 
0" /9 1. i-PrOH l O~sP ~ I 1 
'8' -----...... ON" 'N..A-..O~ aq or dry amine CI/ 'N==C=O 2. pyridine ~ I ® e --'------"--...... 
117 122 
Figure 31-Masui's one pot preparation of sulfamides29 
As part of their research in synthesizing sulfamidates from epoxides the Hudlicky 
group attempted to use C2 symmetric Lewis acid catalysts to form chiral sulfamidates of 
type US which could then be used to access chiral amino alcohols.22 These attempts were 
unsuccessful and it was rationalized that the Lewis acid and the Burgess reagent could 
not coordinate simultaneously to an epoxides for steric reasons. Hudlicky then turned his 
attention toward creating a chiral auxiliary version of the Burgess reagent 124. When 
cyclohexene oxide (104) was treated with 124 a 1: 1 mixture of diastereomeric 
sulfamidates 12Sa-b was produced (Figure 32). The mixture was separable by column 
chromatography and the diastereomeric sulfamidates could be treated to form cis or 
trans-amino alcohols in both enantiomeric series, the latter group of compounds 
produced by the reaction of cis-sulfamidates with ammonium benzoate.3o 
+ 00 
104 
THF, reflux 
.. 
(X0,,,,o ,S~ 
N 
ero 
\ 
M* 
125a 
+ 
M* = menthyl 
Figure 32-Reaction ofHudlicky's chiral auxiliary Burgess reagent with epoxides22 
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2.1.4 Applications of the Burgess reagent in total synthesis 
The Burgess reagent has proven to be very useful in synthesis as a dehydrating 
agent due to its mild reaction conditions. The Burgess reagent is soluble in a wide variety 
of organic solvents and many reactions can be performed at room temperature at neutral 
pH. Its wide range of reactivity has led to its use in the syntheses of many complex 
natural products. 
The first reported use of the Burgess reagent in synthesis was by Crabbe 
who reported the dehydration of several steroidal alcohols (Figure 33).31 Caspi and co-
workers also reported the dehydration of several steroidal alcohols to their corresponding 
0lefIns.32 
o o 
1 
PhH, rt, 75 % 
126 127 
Figure 33-Dehydration of steroidal alcohols by Burgess reagene1 
Stork employed the Burgess reagent in his general method for the synthesis of 
ll-oxygenated steroids (Figure 34).33-35 The Burgess reagent was used to dehydrate 128 
which then underwent an intramolecular Diels-Alder reaction. By this general method, 
Stork synthesized cortisone, adrenosterone, l1-ketoprogesterone, and 11-
ketotestosterone. Dehydration of 128 with Burgess reagent led to the desired Diels-Alder 
precursor 129a as well as the regio-isomer 129b, which did not undergo cyclization and 
was therefore easily separated from the mixture. Further transformations of 130 led to 
131, which was identical to an authentic sample of silylated ll-ketotestosterone. 
- 20-
1 
128 
131 
129a major 
1 
intramolecular 
Diels-Alder 
130 
+ 
129b minor 
Figure 34-Application of Burgess reagent in Stork's ketosteroid synthesis 
Rigby employed the Burgess reagent as a dehydrating agent in his syntheses of 
p-cedrene (134)36 and (+)-narciclasine (136) (Figure 35).37 
~H 1 stf .. ~ .. .. 
132 133 134 
OAe OAe 
TBSO". 0)( 0)( 1. F-, THF 
<0 ° 
.. <0 ° 2. 1, PhH, reflux 
° ° 
OAe ° OAe ° 
135 136 
Figure 35-Rigby's use of the Burgess reagent in the syntheses of cedrene and narciclasine36-37 
In the Kita group's synthesis of both enantiomers of the complex natural product 
fredericamyein A (139), a key step was the dehydration of alcohol 138 (Figure 36).38 Kita 
first employed an anti-elimination under acidic conditions which was successful but only 
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in 51 % yield. They then attempted a Chugaev elimination which was unsuccessful. The 
Burgess reagent however, gave a clean elimination in quantitative yield. 
1 
THF, reflux 
137 138 
139 
Figure 36-Use of the Burgess reagent in Kita's synthesis of fredericamycin A 38 
Recently, Ciufolini and co-workers have employed the Burgess reagent in their 
synthetic studies toward the terpenoid core of sordarin and analogs thereof.39 Alcohol 140 
was treated with Burgess reagent yielding Diels-Alder precursor 141 in 54 % (Figure 37). 
However, attempts at the Diels-Alder cyclization were unsuccessful and another route 
was followed. 
fdi
C02Me 
OH 
TBSO ==--
CNCN 
140 
1 
54% ~:2Me TBSO ==--CNCN 
141 
heat )( .. 
142 
Figure 37-Use of the Burgess reagent in Ciufolini's studies toward the synthesis of sordarin39 
Wipfs synthesis of (+)-curacin A (146) employed both the Burgess reagent (1) 
and PEG supported reagent 11824 in an elegant oxazoline-thiazoline conversion (Figure 
38).40-41 Deprotection of the silyl group of143 proceeded in nearly quantitative yield. The 
resulting alcohol was subjected to cyclodehydration with Burgess reagent to give 
oxazoline 144. Thiolysis followed by cyclodehydration with Burgess reagent (1) gave the 
natural product 146. When PEG supported Burgess reagent 118 was employed In 
thiazoline formation, a modest increase in yield was observed. 
- 22-
OMe ~R 
TBSO 
1. HF, pyridine, 91 % 
.. NH 2.1, THF, 71 % 0)J 
O?v<H 143 H" "H 
144 1 H,S, MeOH, 
Et3N, 66 % 
?'" OMe ~R 1, THF, 54 % 
HO NH ... 
N or 
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H" "H 146 145 
Figure 38-Application of Burgess cyclodehydration in the synthesis of (+)-curacin A 41 
Wipf also employed Burgess cyc1odehydrations and oxazoline-thiazoline 
conversions in the first total synthesis of (-)-thiangazole 42 and the complex marine natural 
product lissoc1inamide 7.43 Wipfs Burgess cyc1odehydration methodology was also 
employed in Ino' s synthesis of yersiniabactin 44, Wipf s syntheses of westiellamide 45 and 
hennoxazole A 46, and Miller's synthesis ofthe peptide fragment ofpseudobactin.47 
Raghavan and co-workers demonstrated the synthetic utility of their sulfilimine 
formation methodology with benzyl Burgess reagent 98b by applying it to the total 
syntheses of (-)-deoxocassine (150) and (+)-desoxoprosophylline (151).48-49 Sulfoxide 
147 was treated with the benzyl Burgess reagent 98b to yield sulfilimine 148. The 
sulfilimine was then used as an internal nuc1eophile to give common intermediate 149 
which was transformed to natural products 150 and 151 (Figure 39). 
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g8 OTBS 98b 
S~ .. p-Tol/@ PhH, O°C-rt 
147 
149 
CbzN 8 OTBS 1. TBAF, THF 
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p-TOI/~~ 2. NBS, H20, PhMe 
148 N~: 
~~~ H H 
(-)-deoxocassine (150) 
H 
(f"OH 
~~~ H OH 
(+ )-desoxoprosophylline (151) 
149 
Figure 39-Raghavan's syntheses of (-)-deoxocassine and (+)-desoxoprosophyUine48-49 
Hudlicky and co-workers employed their chiral auxiliary Burgess reagent 12422 in 
an enantiodivergent formal synthesis of the fungal metabolite (+)- and (-)-balanol 
(155).30,50 The key step was a regioselective opening of epoxide 152 (Figure 40).22 The 
resulting diastereomeric sulfamidates 153a and 153b were separated by column 
chromatography and opened with benzoate to give the trans-amino alcohol moiety. These 
were then further elaborated to formal intermediates of (-)- and (+ )-balanol, 154a and 
154b respectively. 
+ 
152 
OH 
balanol (155) 
THF, reflux 
)0 
36 % 
+ 
M* = menthyl 
~! 
HoD ,~-pDBO 
NBn 0 
154a (-)-balanol 154b (+)-balanol 
intermediate intermediate 
Figure 40-Hudlicky's enantiodivergent fonnal synthesis ofbalano13o • 
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Since its discovery the Burgess reagent (1) has been widely used for dehydration 
reactions in the synthesis of complex natural products. Burgess dehydrations are usually 
high yielding and side reactions are rare. Renewed interest in the Burgess reagent over 
the last twenty years has led to the development of new reactions as well as new versions 
of the reagent further expanding the versatility of this already useful reagent. 
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2.2 Morphine 
2.2.1 Historical uses, isolation, and biosynthesis 
Morphine (3) has been used by humans as an analgesic, antitussant and 
recreational drug for thousands of years. The first recorded use of opium was by the 
Sumerians in about 3400 BC.51 -52 Opium poppies (Papaver somniferum) appeared in 
Egyptian artwork and the Greek and Roman gods of sleep were often depicted with 
poppies. The Swiss physician Paracelsus developed a preparation of opium and other 
ingredients in wine and sold it as a remedy and sleep aid. In Great Britain, several 
tinctures of opium in alcohol were marketed as cough suppressants and sleep aids which 
were frequently administered to children to quiet them. These remedies were sold under 
names such as Street's Infants' Quietness, Atkinson's Infants' Preservative, and Mrs. 
Winslow's Soothing Syrup. 
The British East India company was brought back from the verge of bankruptcy 
by sales of Indian opium to China. The Chinese attempted to prohibit the sales and use of 
Opium in 1839. However, smugglers and American ships still supplied Indian opium to 
China. In 1839, Chinese officials took several British ships hostage and confiscated over 
20,000 chests (1,600 tons). This led British foreign secretary Lord Palmerston to initiate 
war. The goals of the British Crown were to obtain reparations for the insults suffered by 
captured British sailors and officials, to recover the lost revenue from the opium· seized 
by the Chinese and assure the security of British merchants in China. The British easily 
defeated the Chinese and the treaty ending the war opened up four ports to British 
merchants and ceded Hong Kong to Queen Victoria. The first Opium War, however, did 
not fully resolve the dispute over opium trade. Throughout the 1840's and early 1850's 
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the British sought to legalize the opium trade under the pretense that the Chinese could 
not regulate the illicit opium trade as effectively as the British. The second Opium war, 
also known as the Arrow war, began when Chinese officials boarded the British 
registered ship Arrow whose crew was accused of smuggling and piracy in 1856. The 
war ended with a treaty legalizing the import oflndian opium in 1858. At the time of the 
Arrow war, a strong anti-opium trade movement was growing in England. In the late 
nineteenth and early twentieth century, British India became less dependent on opium 
revenue and an anti-opium movement began to take hold in China. This led to a series of 
reductions in opium shipment to China and in 1913, the Indian government stopped all 
opium shipments to China. 52-53 While use of raw opium continues today, most illicit 
opium is converted to heroin which is less bulky, thus facilitating transport.54 
In 1805, the German pharmacist Serturner isolated morphine from raw opium.55-56 
The name morphine comes from Morpheus, the Greek god of dreams. The structure of 
morphine eluded scientists for over one hundred years and its elucidation was reviewed 
by Butora and Hudlicky.57 The correct structure of morphine (Figure 41) was reported in 
1925 by Robinson and Gulland58 and was confirmed by Gates when he published the first 
total synthesis of morphine in 1952.59 
morphine (3) thebaine (157) 
Figure 41-Structure of morphine and related alkaloids 
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Opium is isolated from poppies by scoring the unripe seed pods of P. somniferum 
approximately 98 days after germination. The latex oozes out and is collected. A single 
seed pod can be harvested several days in a roW.52 The timing of the opium harvest is 
important because morphine alkaloids are produced for only a short time. As the seed pod 
ripens, alkaloid production stops and the alkaloids are broken down. 52 While this method 
is still used in places with more primitive farming techniques, most modern commercial 
poppy farms simply harvest the entire plant which is then sold to manufacturers as opium 
straw from which the alkaloids are extracted on a large scale.52 The highest concentration 
of alkaloids is found in the seed pods but thebaine can be found in significant quantities 
in the roots of the opium poppy.52,60 
The biosynthesis of morphine and related alkaloids has been elucidated (Figure 
42). All carbon atoms present come from two molecules of the naturally occurring amino 
acid tyrosine (158). Nature provides an elegant solution to the synthesis of these complex 
molecules that is unrivalled by even the most efficient laboratory synthesis. 
In the first stage of biosynthesis, one molecule of tyrosine is converted to 
dopamine (159) by the action of tyrosine decarboxylase and phenol oxidase. A second 
molecule of (158) is converted to 4-hydroxyphenylacetaldehyde (160). Dopamine (159) 
and 4-hydroxyphenylacetaldehyde (160) are then condensed to form (S)-norcoclaurine 
(161) by the action ofnorcoclaurine synthase. Subsequent methylation and oxidation give 
(S)-reticuline (162a) which is then epimerized to (R)-reticuline (162b) via the 1,2-
dehydroreticulinium ion (163). A microsome bound cytochrome P450 containing enzyme 
then couples carbon atoms 12 and 13 forming salutaridinol (164).61 The ketone at the C-7 
position of salutaridinol is then reduced and acetylated. The free hydroxy group on C-4 
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then attacks, displacing the acetate in a SN2' reaction to give thebaine (157). Thebaine is 
then demethylated by thebaine 6-0-demethylase to neopinone (165)62 which exists in an 
equilibrium with codeinone (166). Reduction of the C-6 ketone by codeine reductase63-64 
yields codeine (156) which is then demethylated by codeine-O-demethylase to morphine 
(3).62 
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Figure 42-Biosynthesis of morphine 
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Thebaine (157) can also be converted to morphine (3) by an alternate pathway 
that accounts for the formation of trace amounts of oripavine (167) found in opium 
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(Figure 43).62 In this alternate pathway, thebaine is converted to oripavine by the action 
of codeine-O-demethylase. Thebaine 6-0-demethylase then converts oripavine to 
morphinone (168) which is in tum converted to morphine by codeine reductase. 
M~~ HO~ HO~ HO~ 1.0 1.0 1.0 1.0 
q Q. ~ q ~ q 
. 1 NMe ~ '. 1 NMe . NMe . NMe 
MeO ::::,... MeO ::::,... o .0 HO"> .0 
thebaine (157) oripavine (167) morphinone (168) (-)-morphine (3) 
Figure 43-Altemate pathway for the conversion of thebaine to morphine62 
2.2.2 Notable syntheses of morphine 
Gates (1952i9 
Gates published the first total synthesis of morphine (3) in 1952 thus confirming 
the structure proposed by Robinson and Gulland twenty seven years earlier. 58 Gates 
prepared both enantiomers of morphine via a resolution of intermediate 176. Gates' 
synthesis was achieved in twenty four steps from 2,6-dihydroxynapthalene (169) with an 
overall yield of 0.01 %. As shown in Figure 44, an iterative nitrosation / reduction / 
oxidation procedure was used to transform 2,6-dihydroxynapthalene (169) into 
intermediate 172. The nitrogen atom was installed by a Michael type addition of ethyl 
cyanoacetate to 172. This was followed by base hydrolysis and decarboxylation to give 
173. The C-ring of the morphine skeleton was installed by a Diels-Alder reaction 
between 173 and butadiene. The D-ring was completed by a reductive cyclization 
yielding keto-Iactam 175. Reduction of 175 followed by methylation of the nitrogen atom 
gave 176 which contains all of the carbon atoms in morphine. At this stage a resolution 
was performed by crystallization of the tartrate salts of 176. The C-6 position was 
hydroxylated in dilute sulfuric acid. Treatment with potassium hydroxide led to the 
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demethylation of the ether at C-4. The C-6 hydroxyl group was then oxidized to ketone 
177. 
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Figure 44-Gates' synthesis of intermediate 17759 
After the tartrate resolution of 176, the stereochemistry was correct at positions 
C-9 and C-13 but epimeric at C-14. Compound 177 was treated with bromine in acetic 
acid. Elimination of HBr gave an a,~-unsaturated ketone which was converted to its 
hydrazone 179a. Hydrazone 179a then equilibrated to the more stable cis fused ring 
system 179b (Figure 45). 
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Figure 45-C-14 epimerization59 
After the epimerization at C-14 was complete, hydrogenation of a.,~-unsaturated 
ketone 181 gave the precursor for the closure of the C-4,C-5 dihydrobenzofuran ring 182. 
Repetition of the conditions for the epimerization of C-14 allowed for the closure of the 
furan ring and installed the C-7, C-8 unsaturation. Acid hydrolysis of phenylhydrazone 
183 followed by reduction with lithium aluminum hydride gave codeine (156) in 27 % 
over two steps. Demethylation using Rappoport's conditions65 gave morphine (3) in 35 % 
yield (Figure 46). 
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Figure 46-Final transformations in Gates' synthesis of morphine59 
Rice 198066 
Rice's formal synthesis of morphine (3) in 1980 is noteworthy as it is the shortest 
and the highest yielding synthesis to date. Rice's synthesis allows for the synthesis of 
both the natural and unnatural enantiomers of hydrocodone. The route is biomimetic and 
involves the isolation of only six intermediates, requires no chromatography and the final 
yield of formal intermediate hydrocodone (185) is an amazing 29 %. 
The synthesis begins with the condensation of amine 186 and acid 187 followed 
by a Bischler-Napieralski reaction to give 188. Intermediate 188 was then resolved with 
(8)-(-)-a-methylbezyl isocyanate. Birch reduction of the more electron deficient aromatic 
ring followed by formylation, protection and bromination gave cyclization precursor 190. 
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MeS03H, THF 
.... 
2. NBA88 % 
Figure 47-Rice's synthesis of cyc1ization precursor 190 
MeO 
HO 
MeO 
188 
1. Li, NH3, THF, 
tBuOH (90 %) 
2.PhOCHO, EtOH 
(94 %) 
189 
Hydrolysis of 190 with formic acid followed by a hydrogen fluoride mediated 
Grewe-type cyclization gave the skeleton of morphine in 60 % yield. Acid hydrolysis of 
formamide 191 gave l-bromo-nordihydro-thebainone (192). I-Bromo-nordihydro-
thebainone (192) was then converted to hydrocodone (185) by a four step sequence that 
proceeded in 79 % yield. The bromine at C-l was removed by hydrogenation, the 
dihydrobenzofuran ring was closed by alpha bromination of the ketone and base-induced 
ring closure. Removal of the aryl bromide and methylation of the nitrogen atom were 
achieved by hydrogenation over palladium on carbon in the presence of acetic acid and 
formaldehyde. When 192 was subjected to hydrogenation without the addition of 
formaldehyde, norhydrocodone (193) was isolated. 
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Meo&~ Sr 
HO b 
NH 
o 
192 
Meo~~ Sr 
HO b 
NH 
o 
192 
1. HC02H, H20, (90 %) 
2. NH4F, HF, 
CF3S03H, (60 %) 
)Do 
Meo~~ Sr 
HO b 
NCHO 
o 
(92%) 
Meo~~ Sr 
HCI, MeOH HO b 
-~---i"'~ 
NH 
o 192 
1. H2, Pd/C, AcOH, HCHO 
2. Sr2, AcOH 
3. NaOH, CHCI3 
4. H2, Pd/C, AcOH, HCHO 
1. H2, Pd/C, AcOH, HCHO 
2. Sr2, AcOH 
3. NaOH, CHCI3 
4. H2, Pd/C, AcOH 
191 
Meo~ 'b 
q 
". NMe 
o 185 
Meo~ 'b 
0, 
'. NH 
o 193 
Figure 48-Final transformations in Rice's formal synthesis of morphine 
Hudlicky 200967 
Hudlicky's 2009 enantiodivergent synthesis of codeine (156) is based in part on 
Parker's strategy used in the synthesis of morphine68-69 and employs a Heck coupling 
similar to Trost's synthesis.70-71 Hudlicky's synthesis (Figure 49) begins with the 
enzymatic dihydroxylation of p-bromoethyl benzene (194) to diol 195. Diol 195 was 
subjected to diimide reduction and the hydroxyl groups were acetate protected. Protected 
diol 196 was treated with methylamine and potassium carbonate to give a secondary 
amine which was protected as a Boc carbamate 197 without purification. The distal 
hydroxyl group was protected as a silyl ether. A Mitsunobu reaction between alcohol 198 
and bromoisovanillin (199) gave intermediate 200 which was the substrate for the first 
Heck reaction. 
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E. coli JM109 (pDTG601) 
10 gIl 
194 
/OYil ~O 
o Br ~NMeBOC 
TBSO"'U 
200 
I ° /O~ HO:::::"" ..-:: 
Br 
199 
198 
1. PAD, AcOH/MeOH 60 % 
.. 
2. AO£O, Et3N, 
DMAP, 79% 
Figure 49-Hudlicky's synthesis of intermediate 20067 
197 
The intramolecular Heck reaction gave cyclized product 201 in 82 % yield. A 
Wittig reaction was used to convert the aldehyde to a vinyl bromide. Bromide 202 was 
subjected to a second intramolecular Heck reaction to complete the phenanthrene core of 
codeine. The C-6 stereochemistry was inverted by a desilylation followed by an 
oxidation/reduction procedure. Deprotection of the Boc carbamate gave 204, the 
enantiomer of Trost's intermediate.7o Hudlicky attempted to repeat Trost's 
hydroamination procedure but was unsuccessful. To convert Trost's intermediate to 
codeine, Hudlicky used an oxymercuration procedure which gave ent-156 in 18 % yield 
(Figure 50). 
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/O~ ::::,.. I ...,;0 
Pd(OAc)2, A92C03 
o Br .. 0 
'-'::: NMeBoc 82 % 
PPh3CH2Br2, t-BuOK 
"'\ .. 0 
. NM B THF, -60 cC, 49 % I e oc X)1 dppf, PhMe, 110 cC, 
TB80'" TB80'" 
200 201 
TB80'" 202 
/O~ /O~ I 1 TFNDCM (1 '4) I 1. TBAF, THF ::::,.. 88 % "::::,.. ... 2. IBX, DMF 
o .",-~ -; H (OA) Et N 0 .",-""\ 3. NaBH4' CoCI3 H20, 
" 'NMe . g. C 2, ~ " NMeBoc MeOH 
'H then LIAIH4 (18 Yo) 'H 72 % over 3 steps . 
HO h- HO h- TB80" 
ent-1S6 204 
Figure 50-Hudlicky's transformation of200 to ent-codeine67 
j Pd(OAch, A92C03, dppp, PhMe, 107 cC, 44 % 
203 
Originally, Hudlicky's strategy for the synthesis of the natural isomer of codeine 
was to perform two sequential Mitsunobu reactions despite low yields in a similar 
sequence.72 The first Mitsunobu reaction would invert the C-5 stereochemistry and the 
second reaction would invert again and couple the A-ring fragment (199). This strategy 
was found to be very low yielding so an alternate path was taken. Hudlicky performed a 
Mitsunobu reaction on 197 using Banwell' s procedure.73 The distal hydroxyl group was 
then converted to tosylate 206. Hydrolysis of the ester, followed by displacement of the 
tosylate, gave epoxide 207. The epoxide was then opened with the potassium salt of 
bromoisovanillin (208). The hydroxyl group was protected as a silyl ether to give the 
enantiomer of 200. The procedure shown in Figure 50 was then followed to convert 
ent-200 to the natural isomer of codeine (156) (Figure 51). Hudlicky's 2009 synthesis is 
noteworthy in that it can be used to synthesize both the natural and unnatural isomers 
from a single starting material without a resolution. This overcomes one of the criticisms 
of the use of enzymatic reactions to produce synthons in that only one enantiomer is 
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produced thus limiting chemists to the synthesis of only one enantiomer of a natural 
product. 
NMeBoc 
DIAD, PPh3, THF 
.. &OPN0282 
197 
/0Y') ~O 
Q Br ~NMe80C 
HO 209 
1 
TBSCI, imidazole, 
DCM, 61 % 
/0Y') 
~O 
Q Br ;"""~NMeBoc 
TBsoN 
OH 
205 
/O~ I 0 
KO ~ h 
Br 208 
DME/DMF (1:1), 
18-crown-6, 75 % 
HO'" 
TsCI, Et3N, DMAP 
.. 
DCM, 73 % 
207 
NMe 
ent-200 (-)-codeine (156) 
NMeBoc 
&OPN0282 
OTs 
206 
1 
NaOMe, MeOH, 
THF, 88 % 
J~e8OC 
0·,(0 
207 
Figure 51-Hudlicky's synthesis of the natural enantiomer of codeine67 
Chida 200874 
Chida's formal synthesis of morphine employed a cascade lohnson-Claisen 
rearrangement to set the C-13 quaternary center. The Claisen rearrangement was 
catalyzed by 2-nitrophenol and is similar to a rearrangement he employed in his synthesis 
of the Amaryllidaceae alkaloid galanthamine.75 
Chida's synthesis begins with tri-O-acetyl-D-glucal (210) which is deacetylated 
and reprotected in a sequence with a yield of 45 % over three steps. Cleavage of the 
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I 
I 
p-anisaldehyde acetal and replacement of the alcohol gave iodide 212. Elimination of the 
iodide to an olefin gave the substrate for a Ferrier's carbocyc1ization, 213. The 
cyc1ization was followed by ~-e1imination to give cyc1ohexenone 214 and proceeded in 
91 %. L-Se1ectride® was employed for a 1,4 reduction and the resulting enolate was 
trapped as a vinyl triflate 215. Suzuki coupling to A-ring fragment 8 and subsequent 
deprotection gave Claisen rearrangement substrate 218. 
1. NaOMe, MeOH CH20Ac ACO".~~ 2. p-anisaldehyde dimethylacetal PPTS, DMF PMP".S)0 0". 0 
ACoN 
210 
3. TBSCI, imidazole, 
DMF 
1. L -Selectride 
,.. 
TBSO .0 
211 
OTt 
PMBOD 
2. Com in's reagent 
o 
PMBO".)) 
TBsoN 
214 TBSO 215 
'0.0 aq Na2C03 
/0:Q"-'::: j Pd(OAch, Ph3P 
1,4 dioxane 
8 B(OHh 
::~: 
PMBO". "-'::: DCM/H20 
TBSO 
DDQ 
216 
/O~ I '0 .0 
HO". "-'::: 
TBSO 
TBAF 
THF 
217 
1. DIBAL, PhMe 
2. Ph3PHBr, MeOH 
NaBr, DME 
3. 12, imidazole, 
Ph3P, THF 
1. Hg(OCOCF3), (20 mol%), acetonel 
acetate buffer 
2. MsCI, Et3N, 
DMAP, DCM 
/O~ I '0 ..0 
HO". "-'::: 
HO 
218 
Figure 52-Chida's synthesis of intermediate 218 
I 
PMBO" i~ 
TBSOUoMe 
212 
!t-BUOK THF 
PMBO',.~O 
TBsoMoMe 
213 
A cascade Claisen rearrangement was used to set the stereochemistry at both C-13 
and C-14. The cascade rearrangement proceeded in 36 % yield. A sequential 
rearrangement from 217 was also explored. 
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/0 
'0 
HO 
2-nitrophenol 
(150 mol%) 
JIIr 
triethylorthoacetate 
(36 %) 
218 219 
222 
EtC02H (45 mol%) '0 JIIr 
triethylorthoacetate 
(87 %) 
TBSO 
2-nitrophenol 
(5 mol%) 
221 
JIIr 
triethylorthoacetate 
(57 %) 
C02Et 
TBAF 
JIIr 
C02Et THF (97 %) 
/0 
'0 
220 
/0 
'0 
JIIr 
/0 
'0 
HO 
220 
222 
Figure 53-Chida's cascade and sequential Johnson-Claisen rearrangements 74 
C02Et 
Following the Claisen rearrangement, the furan ring was completed by 
epoxidation of the olefin and subsequent intramolecular nucleophilic opening of the 
epoxide. Protection of the alcohol followed by reduction of the ethyl esters gave a 
dialdehyde. Friedel-Crafts closure of the B-ring followed by dehydration gave a mixture 
of 224a-b. The mixture was subjected to silylation conditions to give 224a. A reductive 
amination sequence gave (-)-dihydroisocodeine (227). Spectroscopic data for tosylamide 
226 and dihydroisocodeine was matched to that reported by Parker. 69 
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"""'O~ ....... I ~ 1. mCPBA, DCM, (74 %) o C~B ~ 
CO Et 2. TBSCI, Imidazole, I 2 DMF, (99 %) 
"""'O~ I ~ 1. DIBAL (2 eq) C02Et ~ Q, CO Et 2. Montmorillonite 
. 2 K10 
TBSO 
220 223 
"""'O~ I~ 
Q,. ICHO 
RO 
224a,b 
a:R= TBS 
b:R= H 
TBSOTf, DCM, 
2,6-Lutidine 
(75 % over 
3 steps) 
~ O~ O~ ....... I -.;;:::: 1. MeNH2, MeNH3CI,""'" 1-';;:::: THF, then LiBH4 ~ ~ ~ o ICHO 2. TsCI, DMAP, 0 I 
". pyridine ". NMe 
3.TBAF,THF +s 
TBSO (86 % over 3 steps) HO 
Li, t-BuOH """'O~: 
.. 
225 226 
Figure 54-Final steps in Chida's formal synthesis ofmorphine74 
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2.3 Microbial Oxidation of Arenes 
2.3.1 llistory of microbial oxidation of arenes 
The metabolism of arenes by soil bacteria was first reported by Stormer in 1908. 
In 1968, Gibson and co-workers reported that a strain of Pseudomonas putida grew on 
toluene as its sole carbon source.76-77 Cell extracts from this organism oxidized benzene, 
toluene and ethyl benzene at equal rates. Propylbenzene and butylbenzene were 
metabolized slowly while benzenes with larger substituents (pentyl, heptyl, octyl) were 
not oxidized. Cell extracts were incubated with proposed intermediates for the 
degradation of benzene. Phenol and trans-dihydrobenzene glycol were metabolized at a 
much slower rate than catechol and cis-dihydrobenzeneglycoL When cell extracts were 
incubated in the presence of benzene (228), catechol (231), and cis-dihydrobenzene 
glycol (230), catechol was observed to be the only product. This led Gibson to propose 
the mechanism shown in Figure 55 for the oxidation of benzene to catechoL 
01" Cfl dioxygenase [ 0:9 ] ~ .. (X0H ~ V .. ~ 0 ~ OH dihydrocatechol o:~ OH dehydrogenase .. o OH 
228 229 230 231 
Figure 55-Gibson's proposed mechanism for diol and catechol formation by P. putida 76 
Incubation of P. putida with p-chlorotoluene (232) yielded two metabolites 
(+ )-cis-4-chloro-2,3-dihydroxy-l-methylcyclohexa-4,6-diene (233) and 4-chloro-2,3-
dihydroxy-l-methylbenzene (234),77 providing further evidence of a cis-dihydrodiol 
intermediate in the metabolism of aromatic substrates (Figure 56). 
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¢ 
CI 
232 
P. putida 391D 
.. ¢::: 
CI 
233 
+ 
(vOH 
~OH 
CI 
234 
Figure 56-Metabolism ofp-chlorotoluene by P. putida77 
180 labeled oxygen was used to confirm that the hydroxyl groups of the catechols 
originated in molecular oxygen.78 A mutant strain of P. putida was isolated that did not 
have the requisite enzymes to process cis-cyc1ohexadiene diols.79 This allowed for the 
isolation of several diols in sufficient quantity for stereochemical proof. 
Gibson was able to isolate (+ )-cis-2,3-dihydroxy-l-methyl-4,6-cyc1ohexadiene 
(236) produced by the action of the enzyme toluene dioxygenase and confirmed the 
relative stereochemistry was indeed cis.79 Determination of a cis relationship between 
the hydroxyl groups could not be established by NMR analysis of the free diol. In order 
to get a clearer picture of the relationship of the two hydroxyl groups, a more rigid 
structure was needed.79 Diol 236 was protected as a diacetate and condensed with maleic 
anhydride. The resulting Diels-Alder adduct 237 was then hydrogenated and the fully 
saturated tricycle 238 was analyzed by NMR spectroscopy to prove the cis relationship 
(Figure 57). The relative and absolute stereochemistry were later confirmed by X-ray 
diffraction. 80 
235 
o :: Cc 0»' OAc OH 1. AC20 P. putida 39/" ~ JO ~ OH 2. maleic OAc 
anhydride 0 
236 237 
Pd/C °M~ ~aOAc 
----JO~ 0 
H2 ~bOAc 
o 
238 
Figure 57-Proof of relative stereochemistry of P. putida metabolites79 
Proof of the absolute stereochemistry of 236 was published by Gibson in 1973.81 
Hydrogenation of the diol yielded diastereomeric diols 239a-b that were. separable as 
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their monobenzoates. Dio1239b was then oxidized with Jones reagent to (-)-2-(R)-adipic 
acid (240) which proved the absolute stereochemistry was lS,2R (Figure 58). 
1. H2 Pd 
- HO~OH Ce°H 2. BzCI ex:: C( Jones oxidation )Do + 3. separation .-~ OH 4. hydrolysis OH 0 
236 239a 239b (R)-(-)-methyladipic acid 
(240) 
Figure 58-Proof of absolute stereochemistry of P. pUlida metabolite 23681 
2.3.2 Isolation and characterization of toluene dioxygenase (TDO) 
In 1977, Gibson was able to isolate the enzyme responsible for the oxidation of 
aromatic compounds to cis-diene diols. He named this enzyme toluene dioxygenase or 
TDO.82 TDO was discovered to be a three component enzyme composed of a 
flavoprotein and two non-heme iron containing proteins. These proteins required 
electrons from NADH. Further study led to a reliable purification method.83 
Through the study of mutant strains of P. putida, Gibson and Zylstra were able to 
determine the nucleotide sequence of the genes encoding TDO.84 The genes were then 
expressed in a strain of E. coli JM109(pDTG601). The use of E. coli for 
biotransformations of aromatic compounds has many advantages over mutant P. putida 
strains. E. coli has been studied very thoroughly and its growth conditions have been well 
optimized. P. putida requires an aromatic inducer to express TDO, usually toluene or 
chlorobenzene. Because the inducer is also a substrate, it must be separated from the 
metabolite. The recombinant organism, however, uses ~-isopropylthiogalactopyranoside 
(IPTG) as an inducer. The plasmid incorporated into E. coli also contains multiple copies 
of the genes responsible for TDO allowing much greater expression and thus higher 
yields of diols. 
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2.3.3 Substrate scope and specificity 
Dihydroxylations by TDO have been found to occur in a fairly predictable manner 
with respect to regio-, stereo-, and enantioselectivity. After screening a number of 
1,4-disubstituted benzenes, Boyd developed a model to account for and predict the regio-
and stereo selectivity ofTDO oxidations.85 According to Boyd's model, dihydroxylations 
proceed as shown in Figure 59. When the difference in relative size between the two 
substituents (S and L) is greater, the diol is obtained in higher er. 
OH 
OH 
Figure 59-Boyd's model for the prediction of stereoselectivity of TDO dihydroxylations85 
Boyd later expanded his model to include larger, more conformationally flexible 
substituents 86-87 and determined the absolute stereochemistry of the metabolites reported 
in his 1993 publication.88 Boyd's model has also proven to be fairly accurate at prediction 
the regio- and stereochemistry of ortho- and meta- as well as para'- substitution on 
benzene rings (Figure 60).89 
TDO. 
OH 
OH 
Figure 60-Boyd's expanded model for the stereoselectivity ofTDO dihydroxylations89 
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Benzenes substituted with charged or very polar functional groups are often not 
metabolized.89 These substituents include phenols, sulfoxides and sulfones, carboxylic 
acids and amines. When these substrates are metabolized it is usually through pathways 
other than TDO. Nitrobenzene was originally thought to be among the substrates not 
metabolized by TDO but was later shown to be metabolized to a diol which was then 
degraded by other enzymes present in the bacterial cells.90-91 
An ongoing component of the research program in the Hudlicky group is the 
isolation and structural determination of new metabolites ofTDO. In 1992, Hudlicky and 
co-workers isolated several metabolites derived from ortho-chlorostyrene (241).92 This 
was followed a year later by a similar study on ortho-bromostyrene (242).93 Oxidation of 
these substrates led to mixtures of products, as shown in Figure 61. 
Br .... tAOH U OH 
246 (1) 
;)
0 OH 
Br '-'::: 
I~ 
247 (4) 
P. putida 39/D 
III( 
242, x=Br 
P. putida 391D 
)II 
241, x=CI 
Figure 61-0xidation of o-halostyrenes by TDO (ratio )92-93 
CI ... tAOH U OH 
243 (1) 
;SOH CI '-'::: I~ 
244 (1.8) 
CI 
~OH 
U OH 
245 (trace) 
Recently, Hudlicky and co-workers tested several benzoate esters 248 as possible 
substrates of TDO.94 Methyl, ethyl, n-Pr, i-Pr, n-Bu, t-Bu, allyl, and propargyl benzoate 
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esters were tested as substrates to determine the role of steric bulk in oxidation by TDO. 
Methyl, ethyl, allyl and prop argyl benzoate were all metabolized and their corresponding 
diols were isolated in approximately I giL yield. The diols resulting from the oxidation of 
n-Pr and i-Pr benzoate were isolated in trace amounts. n-Bu and t-Bu benzoate were not 
metabolized. 
°OOR 
~I 
~ 
248 
E. coli JM109(pDTG601) 
.. 
R = Me, Et, allyl, propargyl, 
n-Pr, i-Pr 
02XOR ~ OH 
~ OH 
249 
Figure 62-Metabolism of benzoate esters by TD094 
2.3.4 Use of microbial oxidation in synthesis 
There are over 400 known metabolites of TDO, however, relatively few have 
been exploited in synthesis. The majority of TDO metabolites used in synthesis are the 
diols derived from benzene, toluene and monosubstituted halobenzenes.95 
The first use of cis-dihydrodiols was a preparation of polyphenylene (251) 
reported by researchers at Imperial Chemical Industries (lCI) in 1983.96 Diol 230 was 
derivatized as a carbamate or ester 250 and then heated to initialize the formation of 
polyphenylene (Figure 63). 
(X0H ~ OH 
230 251 
Figure 63-Preparation of polyphenylene from 230 
The first application of a TDO metabilite in natural product synthesis was 
reported by Ley and co-workers in the racemic synthesis of (±)-pinitol (255) in 1987 
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(Figure 64).97 Ley's synthesis began with diol 230 which was protected as its benzoate 
252. Treatment with mCPBA gave a diastereomeric mixture of epoxides 253a-b in 14 % 
and 73 % respectively. Epoxide 253b was opened with methanol in camphorsulfonic acid 
(CSA) to give 254 in 88 % yield. Dihydroxylation with osmium tetroxide followed by 
deprotection gave (±)-pinitol. 
(X0H ~ OH 
230 
C:;", OBz (XOBZ 
253b 
BzCI, DMAP, 
.. 
pyridine 
MeOH 
(+)-CSA 
(X0BZ ~ OBz 
252 
mCPBA, DCE 
.. 
phosphate buffer 
pH 8 
(x0BZ + 
253a OBz 
0, (:(BZ 
253b OBz 
QH 
Me0yY0Bz 
~OBZ 
254 
1. OS04, NMO 
tBuOH/TH F IH20 (10:3:1) 
.. 
2. Et3N/MeOH/H20 (1:5:1) 
Figure 64-Ley's synthesis of (±) pinito197 
OH 
Me0yYoH 
HO"'~OH 
OH 
(±)-pinitol (255) 
The fIrst use of diols by the Hudlicky group involved the preparation of 
prostaglandin synthon 259 in 1989.98 This synthesis was the fIrst example of an 
enantioselective synthesis using diols (Figure 65). The diol resulting from the oxidation 
of toluene was protected as its acetonide 256 and then subjected to ozonolysis. 
Hemiacetal 257 was then carefully dehydrated on neutral alumina to 258 which can be 
transformed to prostaglandin E2a 260 by the method of Johnson and Penning.99 
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235 
1. P. putida 39/D 
)10 
2. DMP, TsOH 
Neutral Alumina 
)10 
DME, reflux [ ::XJ< 1 
258 
o 
CC>< o 
259 
[ ~ 1 O~,O>< 
HO 257 0 
o 
Neutral Alumina 
DME, reflux CC>< o 
259 
o 
"\\~C02H 
.0 
-
OH 
260 
Figure 65-Hudlicky's synthesis of prostaglandin synthon 25998 
Hudlicky and co-workers have shown that diols are extremely useful starting 
materials in the synthesis of terpeneslOO-lOl, sugars 102-103, pseudosugars, 104 cyclitols 
105, aza-sugars 106, sphingosines 107-108, and alkaloids of the pyrrolizidine109, 
amaryllidaceaellO-1l8, and morphine67,1l9-120 families. 
Several landmark syntheses, including syntheses of conduritols121 , 
Amaryllidaceae alkaloidsllO-lll ,ll3, heliotridanes109, and triquinanes122, are shown in 
Figure 66. Several recent reviews contain more exhaustive lists of syntheses 
employing microbial dihydroxylation.89,95,123-125 
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Starting material Product Author (year) Reference number 
9H OH 
(X0H HOC
OH Ho"·6··,OH 
~ OH ~ ·"OH Ley (1990) 121 ~ OH 
230 (+)- and (-)-conduritol F (263) 
9H 
Br <o~:: C(" Hudlicky (1992) 110 ~ OH o h- NH 
12 0 
Iycoricidine (264) 
CI HilioH HO H rOH ((H HO"·· HOO Hudlicky (1990) 109 N N 
~ OH (+)- and (-)-trihydroxyheliotridane (265) 261 
9H 
~OH Br ((" (0 I ~ .: OH Hudlicky (1995) 111 ~ OH o h- NH 
12 OH 0 
pancratistatin (266) 
9H 
Br t~:: nOH Hudlicky (1999) 113 
Br ~ OH o h- NH 
262 OH 0 
narciclasine (267) 
C(" ~ Banwell (2004) 122 ~ OH H 
236 (-)-hirsutene (268) 
Figure 66-Landmark syntheses employing microbial dihydroxylation95 
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2.4 Claisen rearrangement 
In 1912, Ludwig Claisen reported a [3,3] sigmatropic rearrangement of allyl vinyl 
ethers or their nitrogen or sulfur analogs 269.126 In his seminal disclosure, Claisen 
described the transformation of phenyl allyl ether (271) to 2-allylphenol (273) and the 
transformation of O-allylated acetoacetate (274) to its C-allyl isomer 275 (Figure 67). 
The Claisen rearrangement quickly became a widely used reaction in organic synthesis. 
l 
6 heat 
271 
x~ 
V heat 
269 
x = 0, N, S 
272 
heat 
() 
270 
273 
yC02Et 
275 
Figure 67-The Claisen rearrangement 
The Claisen rearrangement is generally thought to proceed through a chair- or 
boat-like transition state (277 or 279 respectively) (Figure 68).127 Early kinetic studies of 
the Claisen rearrangement of allyl vinyl ether (276), the simplest structure that can 
undergo Claisen rearrangement, were performed by Schuler who found the kinetics to be 
first order and the energy of activation to be 30.6 kcallmol.128 Since the rearrangement is 
highly exothermic, the Hammond-Leffler postulateI29-130 predicts that the transition state 
is closer in character to the starting material than the product. l3l Gajewski and 
McMichael published kinetic isotope studies back to back and both detenhined that the 
- 52-
i 
"I 
transition state had a certain amount of radical character. l3l -132 However, there is still 
some disagreement on the exact nature of the transition state.133 
/f.-.-:q 
0 -... [ b::(f ] -... ;;;:--g 
276 277 278 
~~ ---... [~~)l ---... \\--} 0 '---0' 0 
276 279 278 
Figure 68-Chair and boat transition states for the Claisen rearrangement 
2.4.1 Variations of the Claisen rearrangement 
In the ninety-eight years since the discovery of the Claisen rearrangement there 
has been many variations of the rearrangement published. Martin Castro provided an 
excellent overview of the variations of the Claisen rearrangement in her 2004 review. 134 
In 1973, Baldwin reported the Claisen rearrangements of zinc enolates 281 
dubbed the Reformatskii-Claisen rearrangement. 135 The Reformatskii-Claisen 
rearrangement proceeds under neutral conditions. Lang reported a variation of the 
Reformatskii-Claisen rearrangement of chlorodifluoroacetates 283 in the presence of 
chlorotrimethylsilane (Figure 69).136 
0 [5Br ] OlnBr Br~o In dust 6 .. .. 0 PhH, heat 
280 281 282 
0 [ OSiMe,] OH 
CIF2CA O In, Me3SiCI FCAO F2CA O .. .. 0 PhH, heat 20 V 
283 284 285 
Figure 69-The Refonnatskii-Claisen rearrangement135-136 
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Because of the greater thermodynamic stability of the C-O double bond relative to 
the C-C double bond, Claisen rearrangements are usually irreversible. However, 
retro-Claisen rearrangements can occur if the reaction reduces strain in the molecule. 
Boeckman showed that bridged bicyclic systems 286 will undergo retro-Claisen 
rearrangements to reduce torsional strain at the bridgehead 137 and Rhoads performed 
retro-Claisen rearrangements on vinylcyclopropane carboxaldehydes 288 (Figure 70).138 
While Rhoads referred to the conversion of 288 to 289 a retro-Claisen rearrangement, it 
is really an oxodivinyl Cope rearrangement. 
H 
--'W H C02CH3 
287 
Hi) o o ... .. 
288 289 
Figure 70-The retro-Claisen rearrangement137-138 
In 1972, Ireland reported the Claisen rearrangement of the lithium enolates of 
allyl esters 291 and the trimethylsilyl enolates of allyl esters 293 (Figure 71 ).139 These 
reactions proceeded at low temperatures and often without the formation of side products. 
Stereoselective enolate formation can be employed to control the stereochemistry of 
Ireland-Claisen rearrangements. 140 
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o 0y 
° 290 
[~]~ 
!TMSCI H~ 
[Q]/ 2~2 
OTMS 
293 
Figure 71-The Ireland-Claisen rearrangement 
In 1994, Uli Kazmaier reported a variation of the Ireland-Claisen rearrangement 
(often referred to as the Kazmaier-Claisen rearrangement) that used a metal to chelate the 
enolate formed by the deprotonation of an ester (Figure 72).141-142 This method was 
applied to the synthesis of several unnatural amino acids of type 297. The 
Kazmaier-Claisen rearrangement proceeds through a boat-like transition state 295 rather 
than a chair-like transition state 296 and is often highly diastereoselective.142 The use of a 
chelating agent allows for reactions at higher temperatures than Ireland-Claisen 
rearrangements as the chelated enolates are much more stable than lithium enolates. 
o 
o 
O~NHPG LDA, ZnCI2 
THF 
294 
PG = Boc 
L = coordinating solvent 
~~~ PG ,L ! " N::'--Zn ';' / "L 
:L'---
:y--o 
o 
295 
chair 
~c:s:J , , L Nft:: \ /: l ,!--I 
/Zn--......eG 0 
L.: 0 
296 
boat 
Figure 72-The Kazmaier-Claisen rearrangement 
- 55 -
10hnson described the Claisen rearrangement of allylic alcohols in an excess of 
triethyl orthoacetate (298) and a catalytic amount of acid, usually propionic acid. 143 
Under acidic conditions, triethyl orthoacetate loses ethanol to form ketene diethyl acetal 
(299). An allylic alcohol 300 adds to ketene diethyl acetal and then undergoes another 
loss of ethanol to generate a mixed ketene acetal 302. The mixed acetal then rapidly 
undergoes a [3,3] sigmatropic rearrangement (Figure 73). The 10hnson-Claisen 
rearrangement is advantageous because only one operation is required as opposed to 
vinyl ether formation followed by pyrolysis. Daub reported 10hnson-Claisen 
rearrangements with trimethyl orthoacetate.144 McGeary and Cosgrove developed a 
method of generating mixed orthoesters and and a triisobutylaluminum catalyzed 
10hnson-Claisen rearrangement that proceeds at room temperature.145-146 
301 
[ 
OEt 1 ~OEt 
299 
302 
Figure 73-The Johnson-Claisen rearrangement143 
rlI'R1 
EtOAO ~R2 
303 
There have been several other variations of the Claisen rearrangement published 
including chiral auxiliary and catalytic reactions. Variants of the Claisen· rearrangement 
not covered here and several syntheses employing Claisen rearrangements are covered in 
Martin Castro's review. 134 
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2.4.2 Use of the Claisen rearrangement in organic synthesis 
The Claisen rearrangement has also been featured in the synthesis of many 
complex natural products including Ireland's synthesis of lasalocid A147, Paquette's 
synthesis of basmane diterpenesl48, Kim's synthesis of pancratistatin149 and 
Mioskowski's synthesis of halomon. 150 
The Claisen rearrangement has been used extensively by the Hudlicky group. A 
Johnson-Claisen rearrangement is featured in Hudlicky's general method for the 
preparation of linear and non-linear triquinanes (Figure 74).151 In the synthesis of linear 
triquinanes 307a, a vinyl unit is added to the carbonyl of 304 and the Johnson-Claisen 
rearrangement takes place on the less substituted olefin to give (306a). To synthesize 
non-linear triquinanes 307b, an alkynyl unit is added to the carbonyl of 304 and the 
cyclic olefin participates in the rearrangement to give 306b. 
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linear triquinanes 307a 
«/ 
~H~ 
305b TMS 
1 
306b II 
1 1MS 
stfo 
non-linear triquinanes 307b 
Figure 74-Hudlicky's general method for the synthesis oflinear and non-linear triquinanes151 
In 1997, Hudlicky reported the synthesis of several unnatural amino acids 310a-d, 
and 31la-d.152 The key step of the synthesis was a Kazmaier-Claisen rearrangement of 
309a-d to 310a-d and 31la-d (Figure 75). This sequence is the basis for our synthesis of 
the C-ring of morphine (3) described in this thesis. 
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R R 0 
ex 1. diimide ex II NHBoc R C02H R C02H ~ OH 2. TDSCI, imidazole O~ L ( ) cr (( ______ .... ~ DA, 2.2 eq ., ::::,... 3. Boc-Gly, DCC ZnCI2 (1.2 e9).. ~ NHBoc + ~ 'NHBoc 
308 OH OTDS TDSO'" TDSO'" 
a: R = Ph 
309 310 311 
b: R= Me 
c: R=CI 
d: R = o-melhoxyphenyl 
Figure 75-Hudlicky's preparation of unnatural amino acids via a Kazmaier-Claisen rearrangement 
Chida's synthesis of morphine (3), described in section 2.2.2 employed a cascade 
lohnson-Claisen rearrangement as the key step that set the stereochemistry at the C-13 
quaternary center and at C-14. The cascade Claisen rearrangement of 218 to 220 
proceeded in 36 %. A stepwise procedure starting from protected diol 217 gave the 
rearranged product in 48 % yield over three steps (Figure 76). 
218 
222 
2-nitrophenol 
(150 mol%) ,. 
triethylorthoacetate 
36% 
....... 0 
EtC02H (45 mol%) '0 ,. 
triethylorthoacetate 
87% 
TBSO 
2-nitrophenol 
(5 mol%) 
221 
,. 
triethylorthoacetate 
57% 
TBAF 
C02Et THF (97 %) 
....... 0 
'0 
220 
Figure 76-Chida's cascade and sequential Iohnson-Claisen rearrangements 
220 
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3. Discussion 
3.1 Introduction 
The first part of the present studies describes the efforts to develop a thermally 
stable version of the Burgess reagent that retains the reactivity of the original reagent. 
Such a reagent would be useful to synthetic chemists who are employing the Burgess 
reagent in reactions at elevated temperatures. At high temperatures, the original Burgess 
reagent is unstable and its decomposition leads to reduced yields. A more stable reagent 
would also require less care in handling and could be stored for longer periods of time. 
The second part of this thesis details the progress toward the total synthesis of 
morphine beginning with the enzymatic dihydroxylation of bromobenzene. As pointed 
out in the Historical Section, the ultimate goal of our synthetic studies of morphine is to 
develop a route efficient enough to compete with isolation of morphine from natural 
sources. Progress toward this goal is discussed herein. 
In addition, the characterization of several new metabolites of toluene 
dioxygenase provides new chiral materials that can be utilized in total synthesis by 
academic and industrial chemists. The characterization of new metabolites helps us to 
better understand the nature of toluene dioxygenase and its strengths and limitations. 
Hopefully, more chemists will realize the environmental benefits of enzymatic reactions 
and be encouraged to incorporate enzymatic reactions into their total synthesis efforts. 
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3.2 New Burgess reagents 
Three new Burgess reagents were synthesized for this study. Also included were 
the original Burgess reagent (1) and the menthyl chiral auxiliary Burgess reagent 124 
(Figure 77). The goal was to stabilize the negative and positive charges with electron 
withdrawing and donating groups respectively as shown in Figure 1 (page I). For the 
electron withdrawing group, we chose trifluoroethanol and for the electron donating 
group we replaced triethylamine with N-methyl piperidine. Although 1 is commercially 
available from Sigma-Aldrich, the commercial reagent is expensive and often contains 
impurities.13 The Burgess reagent was prepared as described in Burgess' Organic 
Syntheses paper.153 Menthyl Burgess reagent 124 was prepared by the method described 
by Hudlicky.22 
313 
Figure 77-Burgess reagents employed in this study 
Reagent 313 was prepared by Burgess' method with the substitution of 
triethylamine with N-methylpiperidine. Fluorinated reagents 312 and 314 required more 
modification of Burgess' procedure to synthesize. Chlorosulfonyl isocyanate (117) was 
treated with 2,2,2-trifluoroethanol in benzene to give carbamate 316. Carbamate 316 
proved to have very limited solubility in benzene, therefore, the solvent wa,s switched to 
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THF. Treatment of 316 with 2.2 equivalents of triethylamine yielded reagent 312 and 
treatment of316 with N-methylpiperidine gave 314 (Figure 78). 
0,/9 
's' CI ..... 'N=C=O 
117 
MeOH 
PhH, r.t. 
PhH,O°C 
N-methylpiperidine 
(2.2 eq) 
PhH,O°C 
313 
N-methylpiperidine 0" /P ~ 
(2.2 eq) G'S'N/"-....O ............... CF 
------l..... E!:l" e 3 
THF, 0 °c 
314 
Figure 78-Preparation of Burgess reagents 
The reactivity of the new Burgess reagents was compared to the original Burgess 
reagent and the menthyl reagent 124 in a series of reactions. 154 The results are shown in 
Table 1. Each reagent was tested in a dehydration reaction, reactions with epoxides, and 
with styrene dioL Yields of the dehydration of317 to 318 were about 30 % higher when 
the new Burgess reagents were employed. In the reaction with cyclohexene oxide (104) 
the N-methylpiperidine reagent gave a 16 % improvement in yield over that observed 
with the original reagent 1. The fluorinated reagents however, gave a significant decrease 
in yield. We believe that this is because the nitrogen atom bearing the negative charge is 
too stable and not nucleophilic enough to open the epoxide. When the more activated 
allylic epoxide 152 was treated with our Burgess reagents we did see higher yields of 
sulfamidates compared to the opening of 104. The fluorinated reagents 312 and 314 were 
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nucleophilic enough to open epoxide 152 and gave sulfamidate 324 in modest yield. In 
the reaction of reagents 1 and 313 we obtained yields similar to those reported by 
Nicolaou.13-14 Reagents 312 and 314 gave only sulfonation of the alcohol, which is 
consistent with the mechanism for the formation of sulfamidates from diols proposed by 
Nicolaou. 13-14 The formation of dicarbamate 322 was quite surprising. However this can 
also be rationalized by invoking a bis-sulfonated intermediate 325, which, for steric 
reasons, may not undergo intramolecular displacement at the benzylic position. A less 
sterically demanding intramolecular displacement may take place yielding sulfamidate 
326, which then could be substituted at the benzylic position by the carbamate anion 327, 
created by the displacement of the second equivalent of 124. Another option is an 
intramolecular SN2 type reaction similar to the mechanism· described by Burgess for the 
formation of carbamates from primary alcohols (Figure 79).3 
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Table I-Reactivity trends of the new Burgess reagents in dehydration, reactions with oxiranes, and with 
styrene diol 
OH 
0) 0 0 0 0 OH Starting material Ph~OH 
317 104 152 74 
Reagent Product(s) 
CXO\~O CXO\~O o 0 MeO CO Meo,J(N-S~O )::N 0 ' ~ ~ N' ''0 N 0 o ~ Me~O Me~O Ph~O ~/~ Ph 0 0 
57 113 
318 (63 %) 109 (40 %) 319 (30 %) 75:107 (77 %) (98:2) 
CXO~O CXO~O 0 CO RO)lNH H ' " ~ NU 124 N 0 R~O R~O Ph~NnOR 
0 
318 (60 %) 320 (35 %) 321 (36 %) 322 (70 %) 
R=Menthyl R=Menthyl R=Menthyl 
CO CXO~O CXO~O , ~ ~ N' U 312 N 0 sulfonation only F3CH2C~0 ~O F3CH2CO 
318 (93 %) 323 (12 %) 324 (53 %) 
CXO~O CXO~O o 0 MeO CO MeO,J( S~O )=N 0 313 ' " ~ N' ''0 N- \ 0 ~ N 0 ~O ~/" Me~O Me~O Ph Ph 0 0 75 113 
318 (94 %) 109 (56 %) 319 (57 %) 57:107 (82 %) (95:5) 
CO CXO~O CX°'s~O , ~ ~ N'U 314 N 0 sulfonation only ~O F3CH2C~0 F3CH2CO 
318 (93 %) 323 (17 %) 324 (45 %) 
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(0-S.o2 OH 0~S'N~C02R 
~OH 124 00 9 otN-Co,R 1-":::: ~ • 1.0 • 
.0 C 0'S~~'C02R e 
74 325 O2 326 
NHC02R 
327 
R=menthyl or 
O2 0 Cy~S'N~C02R 
RO)lNH H 
o?O -..:::: .. 1 e Ph~NnOR .0 C 'S~N,CO R 
o 2 0 
325 2 322 
Figure 79-Possible mechanisms for the formation of322 
3.3 Stability studies 
To determine the thermal stability of the reagents, we chose to follow their 
decomposition in THF-ds at 50°C and at reflux by monitoring the content of the sample 
by 13e NMR. Originally, we sought to use IH NMR but as the reagent decomposed, there 
was quite a bit of signal broadening and the signals arising from the decomposition 
products often overlapped the reagent signals. A timed series of 13e NMR spectra were 
recorded for each reagent. For each spectrum the peak area of the carbamate 13e signal 
(around 157 ppm) was determined by direct integration and calibration against solvent 
Be signal corresponding to THF-ds at 64.6 ppm. The magnitude of the carbamate 13e 
signal in the fIrst spectrum was set at 100%.154 The results are shown in Figures 80 and 
81 and are compared with those obtained for the original Burgess reagent as well as its 
menthyl chiral auxiliary version. [The plots shown are the actual decays with percent 
content illustrated on the left.] 
As seen in Figure 80, all reagents are stable at 50°C for several hours. The 
original Burgess reagent (1) and menthyl reagent 124 decompose at the fastest rate and 
have half-lives of216 and 198 minutes respectively. The fluorinated reagent 312 shows a 
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modest increase in stability. The N-methylpiperidine reagents 313 and 314 are stable at 
50°C for over 12 hours. At reflux, the half1ives of 1 and 124 drop dramatically to 19 and 
13 minutes respectively and are undetectable after one hour. Again, reagent 312 shows an 
increase in stability. The N-methylpiperidine reagents 313 and 314 are the most stable 
and decomposition is negligible for over three hours at reflux in THF (Figure 81). 
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Figure 80-Decomposition of Burgess reagents at 50°C in THF-ds as a function oftime 
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Figure 81-Decomposition of Burgess reagents at reflux in THF -dg as a function of time 
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Figures 82-86 show the decomposition of each reagent at both 50°C and at reflux 
to illustrate the relative rates of decomposition at reflux than at 50 °Co Reagents 1, 124, 
and 312, decompose much more rapidly at reflux than at 50°C. The more stable 
N-methyl piperidine reagents 313 and 314, do not show as much of a decrease in stability 
at refluxo 
0) 80 c 
c 70 om 
E 60 
~ 50 
- 40 c Q) 
30 (2 
Q) 20 a. 
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Figure 82- Decomposition of 1 at 50°C and at reflux 
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Figure 83- Decomposition of 124 at 50 °C and at reflux 
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Figure 84- Decomposition of 312 at 50°C and at reflux 
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Figure 85- Decomposition of 313 at 50°C and at reflux 
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Figure 86- Decomposition of 314 at 50°C and at reflux 
The rapid decomposition of reagents 1 and 124 explain why yields of 
sulfamidates from epoxides are often low compared to the yields of sulfamidates from 
1,2-diols. The decomposition studies as well as the reactivity profiles show that reagents 
312 and 313 are likely the most useful to synthetic chemists. The minor increase in 
stability of reagent 314 does not offer any advantages in reactivity at least in the cases 
involving oxiranes. 
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3.4 Synthesis of morphine C-ring fragment 
The synthesis of the C-ring of morphine (3), as outlined in the Introduction on 
page 2, began with the microbial oxidation of bromobenzene (13) to diol 12. 
Fermentation took place III a 15 L Biostat fermentor (12 L working volume). 
Approximately 20 gIL diol was isolated from the fermentation. Diol 12 was then 
subjected to diimide reduction of the distal double bond to give diol 328. The distal 
hydroxyl group was then protected as a silyl ether 329. The proximal hydroxyl group was 
then coupled to Boc-protected glycine. A Kazmaier-Claisen rearrangement was then 
performed to give amino acid 330. The crude amino acid was then methylated with 
diazomethane to give the C-ring fragment as a mixture of diastereomers 10 (Figure 82). 
Br 6 E. coli JM109 (pDlG601) ~OH 
13 
Br 
aDH OTDS 
329 
68 % over 2 steps 
-20 gIL 
BocGlyOH, DCC 
• DMAP, DCM, 70 % 
UOH 
12 
Br C02Me 
.»-'NHBOC 
lDSO"V 
10 
Br 
PAD, AcOH, MeOH 
.. ~OH lDSCI, imidazole .. DMF, _8°C, 3 days 
90 % o °C, 72 % 
UOH 
328 
LDA (2 eq) 
ZnCI2, DCM 
Br C02H 
.»-'NHBOC 
TDSO"V 
330 
Figure 87-Synthesis of the C-ring fragment of morphine 
Diastereomeric mixture 10 was separated by column chromatography to give 
C-ring fragment 9 and its diastereomer 331 in a 1:4 ratio. The undesired diastereomer 331 
was then recycled by epimerization and separation (Figure 83). 
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epimerization conditions 
! 
Br C02Me Br C02Me .~NHBOC ------o .. ~ .N·"NHBoC 
TDSO" U TDSO" U 
10 331 
Br C02Me 
+ .~NHBOC 
TDSO"U 
9 
Figure 88-Separation of diastereomers and recycling of 331 
The original epimerization conditions took five days to complete and gave a 2:1 
ratio of331:9. This became a significant bottleneck in the synthesis of9, so we undertook 
an optimization of the epimerization (Table 2). In Table 2, the yield refers to the total 
recovery of both diastereomers. Changing the solvent from THF to DME (entries 2-4) 
. allowed the time to be decreased from five to three days. Increasing the equivalents of 
DBU helped to improve the ratio of331:9 but led to slightly lower recovery (entries 3-4). 
A neat reaction in DBU led to major decomposition (entry 5). This data led us to 
determine that the optimal conditions, were 0.5 eq DBU in DME for three days (entry 4). 
These conditions gave us a good dr, shorter reaction times than the original conditions, 
and low decomposition. 
Table 2-0ptimization of epimerization conditions of 331 
Entry Solvent eq DBU Temperature Time Yield of 10 Ratio (OC) (d) (%) 331:9 
1 THF 0.1 66 5 80 2:1 
2 DME 0.1 85 3 85 2:1 
3 DME 1 85 3 70 1 :1 
4 DME 0.5 85 3 80 1:1 
5 neat excess 120 2 20 1 :1 
3.5 Coupling of A-ring fragment 
With the C-ring fragment 9 in hand, we went on to explore the preparation of the 
A-ring fragment 8 and the coupling of 8 and 9. Our original preparation of 8 involved a 
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three step sequence starting from guaiacol (332). This sequence however gave 8 in only 
30 % yield and unreacted guaiacol was difficult to remove. A search of the literature 
yielded a one step preparation of 8 by Snieckus 155. Snieckus' procedure involves a 
directed ortho metalation of 1,2-dimethoxybenzene (335) followed by quenching with 
trimethylborate (Figure 84). This one-pot procedure gave 8 in 85 % yield and was easily 
performed on a multi-gram scale. 
/0X) Br2 /OJQ 
.. HO :::::,... 
HO :::::,... 
Br 
332 333 
1. nBuLi, TMEDA 
2. B(OMeh 3. HCI 
335 
Mel /OJQ 
." 
'0 :::::,... 
/0Y) 
'O~ 
B(OHh 
8, (85 %) 
Br 
334 
1. nBuLi, B(OMeh 
.. 
2. HCI 
Figure 89-Preparation of A-ring fragment 8 
/OJQ 
'0 :::::,... 
B(OHh 
8, (30 % 
over 3 steps) 
The A-ring (8) and C-ring (9) fragments were then joined by a Suzuki coupling 
(Figure 85). The initial conditions employed a biphasic reaction in benzene and water. 
However, the yields were not always reproducible and we worried about hydrolysis of the 
methyl ester. The conditions were optimized as shown in Table 3. The palladium 
tetrakis(triphenylphosphine) varied between batches and seemed to have an effect on 
yields and was therefore replaced with Pd( dppf)2. The use of Pd( dppf)2Ch and CsOAc in 
THF gave reproducible reactions in good yield. Substituting CsOAc for CS2C03 
improved the yield by a further 19 %. 
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/OY/l 
'O~ 
B(OHh 
8 
Entry 
1 
2 
3 
+ 
Br C02Me .~NHBOC 
TDSO"V 
9 
Conditions 
Figure 90-Suzuki coupling of 8 and 9 
Table 3-Optimization of Suzuki coupling 
'0 
TDSO'" 
Solvent Catalyst Base Phase transfer 
<ment 
benzene Pd(PPh3)4 Na2C03 TBAB (aq) 
THF Pd(dppfhCl2 CsOAc none 
THF Pd(dppfhCl2 CS2C03 none 
3.6 Synthesis of Claisen substrates 
NHBoc 
7 
Yield 
1%1 
60-75 
70 
89 
Several substrates for the 10hnson-Claisen rearrangement were synthesized from 
intermediate 7. The first substrate synthesized was alcohol 338. This was done by 
removing the silyl ether of 7 followed by a Mitsunobu reaction to invert the 
stereochemistry of the alcohol. Deprotection proceeded smoothly and the product of the 
Mitsunobu reaction 337 was obtained in good yield. Hydrolysis of the benzoate ester in 
methanol gave 338 in 85 % yield (Figure 86). 
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'0 
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.. 
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Figure 91-Synthesis of alcohol 338 
NHBoc 
337 
The next substrate synthesized for the Claisen rearrangement was acetate 340. 
This was prepared by simultaneously removing the benzyl ester and Boc protecting 
groups of 337 to give free amine 339 and then re-protecting the amine as its acetate 
(Figure 87). 
337 
, 
TFA/MeOH (4:1) 0 
.. 
36% 
339 
/0 
pN02PhOAc '0 
.. 
Et3N, MeOH, 
60% 
HO 
Figure 92-Preparation of CIa is en substrate 340 
NHAc 
340 
The final Claisen substrate prepared was cyclic carbamate 6. Diester 337 was 
reduced with lithium aluminum hydride to give alcohol 341. Treatment of 341 with two 
equivalents of sodium hydride gave carbamate 6 in 80 % yield (Figure 88). /0» /O~ /O~ '0 I .0 C02Me LiAIH4, THF '0 1.0 OH NaH, DMF '0 1.0 0 .. .. )=0 
~ NHBoc 91 % ~ NHBoc 80 % ~ N H 
BzO HO HO 
337 341 6 
Figure 93-Preparation of cyclic carbamate 6 
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3.7 Claisen rearrangement 
All attempts at performing the planned Johnston-Claisen rearrangement failed to 
yield the desired rearranged product of type 342 (Figure 89). The results· of several 
attempts are shown in Table 4. 
conditions 
Substrate )( . 
R 
342 
Figure 94-Attempted Iohnson-Claisen rearrangement 
The first substrate tested in the Claisen rearrangement was 338. The substrate was 
subjected to the conditions employed in Chida's synthesis of morphine.74 Unfortunately 
the high temperature and acidic conditions led to the loss of the Boc protecting group. 
The only product isolated was acetamide 340 in a very low yield. We then attempted the 
rearrangement on 340 but after three days only starting material was isolated. We then 
turned our attention to cyclic carbamate 6. Our rationale was that the C-13 (morphine 
numbering) position would be more accessible without the steric bulk of the methyl ester 
and amine. Unfortunately, repeating Chida's conditions on 6 led only to decomposition. 
We then subjected 6 to more traditional Johnson-Claisen conditions, using propionic acid 
and triethyl orthoacetate. These conditions also lead to decomposition. In the final 
attempt at the rearrangement, we used McGreary and Cosgrove's TIBAL catalyzed 
Johnson-Claisen rearrangement. 145 This reaction led only to the elimination of the 
hydroxyl group to a diene (Table 4). At this point, it is believed that the nitrogen atom 
must have some effect that prevents the rearrangement as the presence of nitrogen is the 
only major difference between our Claisen substrates and Chida's. 
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Table 4-Substrates and conditions attempted in Iohnson-Claisen rearrangement 
Substrate Conditions Product 
......... 0 
........ 0 trimethyl orthoacetate, 
o-Nitrophenol (10 mol %), NHAc NHBoc 140 ac, 3 days 
HO 
338 340, -5 % 
......... 0 
trimethylorthoacetate, 
o-Nitrophenol (10 mol %), 
NHAc 140 ac, 3 days NHAc 
HO 340 
HO 
340,60 % 
......... 0 
........ 0 0 triethyl orthoacetate, 
)=0 o-Nitrophenol (10 mol %), decomposition 
N 140 ac, 3 days 
H 
HO 
6 
........ 0 0 triethyl orthoacetate, 
)=0 propionic acid (10 mol %), decomposition 
N 160 ac, 3 days 
H 
HO 
6 
......... 0 ......... 0 
........ 0 0 1. Diethyl ketene acetal, ........ 0 0 
)=0 neat, rt, 2 hours )=0 
N 2. TIBAL (1 eq), rt, 14 N 
H hours H 
HO 
6 40% 
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3.8 Biotransformations 
A series of halogen substituted benzoate esters were tested as substrates of TDO. 
The substrates were first tested in Fernbach shake flasks. Approximately 100 mg was 
incubated with E. coli JMI09(pDTG601) at 35 DC for 6 hours. The appearance of 
metabolites was followed by TLC. In the event that the ester was metabolized, cells were 
separated from the broth by centrifugation and the supernatant was extracted with EtOAc 
and a preliminary NMR spectrum was acquired. A large scale fermentation was then 
performed with the particular substrate and the metabolites were characterized. As shown 
in Table 5, all meta- and para-substituted benzoates were not metabolized. Ortho-
substituted benzoates were found to be substrates although the metabolites were produced 
in relative low yields compared to the 1.3 giL yield of unsubstituted methyl benzoate. 94 
Fluoro-substituted benzoate 343 yielded only one metabolite while chI oro- and bromo-
substituted benzoates 347 and 351 gave a mixture of diols. Iodo- substituted methyl 
benzoate 355 gave only a single metabolite. This trend is in accordance with Boyd's 
model for predicting the regio-chemistry of dihydroxylation by TDO.89 In the case of 
343, the ester directs the regiochemistry of dihydroxylation. The increasing steric bulk of 
chlorine and bromine lead to a mixture of metabolites and in the case of iodine 
substituted benzoate 355 the iodine atom directs dihydroxylation. At the time of this 
writing, the absolute stereochemistry of the isolated metabolites has not yet been 
determined. The relative stereochemistry of all metabolites was determined by 2D NMR 
(H,H COSY, HSQC, and HMBC). The physical and spectral properties of344 have been 
fully characterized and preliminary characterization has been achieved for metabolites 
348, 349, 352, 353, and 356. It was found that like the diols isolated from the 
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fermentation of unsubstituted benzoate esters (249), metabolites where dihydroxylation 
occurred adjacent to the ester (344, 348, and 352) were stable at room temperature and 
amenable to purification by column chromatography. Metabolites that possessed 
dihydroxylation adjacent to the halogen atom (349, 353, and 355) were much less stable 
and upon chromatography, would re-aromatize to give phenols. 
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Table 5-Metabolism of halogen substituted benzoate esters by TDO 
Starting material Products (Yield) 
15M. ~ct F -..::::: F ~ OH 1.0 ~ OH 
343 344 (0.05 gIL) 15M• 1-"::::: No conversion 
F .0 
345 
QM. 
1-"::::: 
.0 No conversion 
F 
346 
'8M. u· M.~~H CI -..::::: CI ~ OH 1.0 ~ OH ~ OH 
347 348 (0.47 gIL) 349 (.035 gIL) 15M• No conversion 
CI .0 
350 15M• '5. M.O'C~H Br -..::::: Br ~ OH 
1.0 ~ OH ~ OH 
351 352 353 
QM. 
No conversion 
Br 
354 15M. I -..::::: M.~C~H 
1.0 ~ OH 
355 356 
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4. Conclusions and future work 
We have developed the synthesis for and measured the stability of several 
Burgess reagents and tested their reactivity towards epoxides, diols and in dehydration 
reactions. We found that reagents 312 and 313 are likely to be the most useful to 
synthetic chemists in terms of stability and reactivity towards alcohols, epoxides, and 
diols. Other variants of the Burgess reagents such as Nicolaou's reagents 98a-e and 
Wipfs PEG supported reagent 118 may benefit from increase in stability by replacing the 
triethylamine portion of the reagent with N-methylpiperidine. 
Our proposed synthesis of morphine (3) proceeded to the Johnson-Claisen 
rearrangement step which was ultimately unsuccessful. As shown in Figure 90, the 
Johnson-Claisen substrates described in this thesis differ only slightly from Chida's 
intermediate 219. The presence of a carbamate may prevent the reaction from proceeding 
as envisioned. The carbamate may also impart lower stability on our substrates thus 
leading to the decomposition observed in several of our reactions. 
....... 0 .......0 
'0 0 FO '0 
C02Et N NHBoc NHAc H 
HO HO 
219 6 338 340 
Figure 95-Cbida's intennediate compared to Claisen substrates prepared in this thesis 
Another strategy would be the preparation of a diene of type 357 followed by a 
cycloadditions of a ketene acetal. Methylation of the nitrogen atom to produce 360 may 
prevent the problems encountered in performing the Johnson-Claisen rearrangement 
(Figure 91). Work on the completion of the synthesis is currently being undertaken by 
Mr. Vimal Varghese. 
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....... 0 ....... 0 
R°Ir°R 
....... 0 
'0 ----.- '0 '0 
------.-
------------.-
or 
R R R NHBoc 
RO 
HO 
RO 359 338 357 358 
....... 0 
....... 0 
'0 0 '0 o '0 0 )=0 -------.- )=0 ---------.- )=0 
N N Et02C N H \ \ Me Me 
HO HO 
6 360 361 
Figure 96-Proposed cyc1oaddition strategy and methylated Claisen substrate for the completion of the 
synthesis of morphine 
Several new metabolites of toluene dioxygenase have been discovered. More 
complete characterization, proof of absolute stereochemistry and optimization of the 
fermentation procedure need to be undertaken by future workers in this area. 
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5 Experimental section 
5.1 General 
All non-hydrolytic reactions were carried out under an inert atmosphere. Glassware used 
for moisture-sensitive reactions was flame-dried under vacuum and subsequently purged 
with inert gas. THF, toluene and benzene were distilled from sodiumlbenzophenone. 
DCM, triethylamine, and N-methylpiperidine were distilled over calcium hydride. Flash 
column chromatography was performed using Silicyde Siliaflash P60 230-400 mesh 
silica gel. Analytical thin-layer chromatography was performed using EMD Chemicals 
TLC Silica Gel 60 F254 plates. Melting points were measured on a Thomas-Hoover 
melting point apparatus and are reported uncorrected. IR spectra were obtained on a 
Perkin-Elmer FT-IR 1600 Series Spectrum One instrument. IH and l3C NMR spectra 
were obtained on either a 300 MHz Broker or a 600 MHz Bruker instrument. Mass 
spectra were acquired on a Kratos Concept 1 S High Resolution EIB mass spectrometer. 
Ionization methods were either electron impact (EI) or fast atom bombardment (FAB) on 
a N-bromo-acetamide (NBA) matrix. Specific rotation measurements are given in deg. 
cm3 g-l dm-l and were recorded on a Perkin-Elmer 341 Polarimeter. Large scale 
fermentation was performed in a 15 L Sartorius (formerly B. Braun) Biostat C fermentor. 
Combustion analyses were performed by Atlantic Microlabs, Norcross, GA, U.S.A. 
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5.2 Preparation of new Burgess reagents 
2,2,2-Trifluoroethyl chlorosulfonylcarbamate (316) 
2,2,2-Trifluoroethanol (3.36 mL, 46 mmol) in dry benzene (10 mL) was added dropwise 
to chlorosulfonyl isocyanate (4.0 mL, 46 mmol) in 15 mL of dry benzene at room 
temperature. When the addition was complete, the reaction mixture was stirred for 30 
min. The product, 2,2,2-trifluoroethyl chlorosulfonylcarbamate (316), was precipitated 
with cold hexanes as white crystals (10.25 g, 42 mmol, 92%); mp 80-82 °c (C6H6); IH 
NMR(CDCh, 300 MHz) (5 8.44 (m, IH), 4.66 (q, J= 7.9 Hz, 2H) ppm; BC NMR (CDCh, 
75 MHz) (5 147.7, 122.0 (q, J= 278.8 Hz), 62.9 (q, J= 38.6 Hz) ppm; IR (KBr) v 3167.6, 
2931.6, 2637.9, 1750.3, 1483.9, 1396.8, 1166.0 em-I; LRMS (FAB+NBA matrix) mJz 
242, 149 (18.9), 99 (41.3), 73 (25.9), 59 (80.8), 49 (100.0); HRMS calcd. for 
N ,N-Diethyl-N-[(2,2,2-trifluoroethyloxycarbonyl)amino] sulfonyl-ethanaminium, 
inner salt (312) 
2,2,2-Trifluoroethyl chlorosulfonylcarbamate (316) (2.0 g, 8.3 mmol) in 50 mL dry THF 
was added dropwise to triethylamine (2.90 mL, 20.8 mmol) in 20 mL dry THF in an ice 
bath. Once the addition was complete, the reaction was stirred for additional two hours. 
Triethylammonium chloride salt was filtered and the solvent removed i1} vacuo. The 
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product (312) was recrystallized twice from dry THF (1.91 g, 6.2 mmol, 75 %); mp 77-79 
°C (THF); IH NMR (CDCh, 300 MHz) 84.48 (d, J= 8.6 Hz, 2H) 3.84 (q, J= 7.8 Hz, 6H) 
1.44 (t, J= 9.5 Hz, 9H) ppm; 13C NMR (THF(ds) , 150 MHz) 8 155.4, 123.8 (q, J= 277.4 
Hz), 60.1 (q, J= 35.8 Hz), 50.6, 8.5 ppm; IR (KBr) v 3167.6, 2986.1, 2931.6, 2676.8, 
2637.9, 2107.9, 1750.3, 1691.2 cm-I; LRMS (FAB+NBA matrix) mlz 307, 239 (30.8), 
102 (100.0),86 (20.0); HRMS calcd. for C9HISF3N204S: 307.0934, found: 307.0930. 
N-Methyl-N-[(methyloxycarbonyl)amino] sulfonyl piperidinamininm, inner salt 
(313) 
Methyl chlorosulfonylcarbamate (315) (6.83 g, 39 mmol) in benzene (30 mL) was added 
dropwise to N-methylpiperidine in benzene (20 mL) cooled in an ice bath. Once the 
addition was complete, the reaction was stirred for additional two hours. N-Methyl 
piperidinium chloride salt was filtered off and the solvent was removed in vacuo. The 
product was recrystallized two times from dry THF to yield 313 (6.6 g, 28 mmol, 71 %); 
mp 87-90 °C (THF); IH NMR (CDCh, 300 MHz) 8 3.72 (s, 3H), 3.60 (m, 2H), 3.45 (m, 
2H) 3.14 (s, 3H) 1.81-2.00 (m, 6H) ppm; 13C NMR (CDCh, 75 MHz) 8 158.2,54.7,53.3, 
40.1,21.6,20.6 ppm; IR (KBr) v 3206.4,2951.4,2869.3,2686.4,2110.2,1704.5,1470.7 
cm-\ LRMS (FAB+NBA matrix) mlz 237,205 (34.3), 100 (100.0), 70 (11.2). 
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N-Methyl-N-[(2,2,2-trifluoroethyloxycarhonyl)amino]sulfonyl-piperidinaminium, 
inner salt (314) 
2,2,2-Trifluoroethyl chlorosulfonylcarbamate (316) (4.0 g, 17 mmol) in 30 mL dry THF 
was added dropwise to N-methylpiperidine (3.80 g, 38 mmol) in 20 mL dry THF at 0 CC. 
Once the addition was complete, the reaction was stirred for an additional two hours. 
N-Methylpiperidinium chloride salt was filtered off and the solvent removed in vacuo. 
The product was recrystallized two times from dry THF to yield 314 (2.4 g, 7.9 mmol, 48 
%); mp 79-81 cc (THF); IH NMR (CDCh, 300 MHz) D 4.48 (q, J= 8.5 Hz, 2H), 3.63 (m, 
2H), 3.45 (m, 2H), 3.15 (s, 3H), 1.82-1.99 (m, 6H) ppm; 13C NMR (CDCh , 150 MHz) D 
156.1, 123.2 (q, J= 277.8 Hz), 61.7 (q, J= 36.0 Hz), 54.8, 40.2, 21.4, 20.6 ppm; IR (KBr) 
v 3425.3, 2964.1, 2872.7, 2716.4, 2127.0, 1712.9, 1470.3 em-I; LRMS (FAB+ NBA 
matrix) mlz 305, 205 (26.7), 137 (3.9), 100 (100.00); HRMS calcd. for C9HI5F3N204S: 
305.0783, found: 305.0764. 
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General procedure for dehydration of 1,2,3,4 tetrahydro-l-naphthol with Burgess 
reagents 
1,2,3,4-Tetrahydro-l-naphthol (1.83 mmol) and Burgess reagent (2.10 mmol) were 
dissolved in dry benzene (5 mL) at room temperature, the reaction mixture was brought 
to reflux temperature and monitored by TLC. Reactions were stopped after 2 hours. 
General procedure for reactions of Burgess reagents with oxiranes 
The appropriate Burgess reagent inner salt (9.2 mmol) was added to a stirred solution of 
the oxirane (4.0 mmol) in THF (20 mL) at room temperature in a single portion. The 
resulting reaction mixture was brought to reflux immediately by submerging it into a 
preheated oil bath (80°C). The reaction mixture was stirred until complete consumption 
of the oxirane (TLC), then cooled to room temperature and filtered through a plug of 
silica. The reaction mixture was concentrated, and the resulting residue was purified by 
flash column chromatography using an appropriate solvent gradient to yield the 
sulfamidate product(s). 
General procedure for reactions of Burgess reagents with diols 
l-Phenyl-l,2-ethanediol (3.7 mmol, 1.0 equiv) was dissolved in anhydrous THF (10 mL) 
and Burgess reagent (9.3 mmol, 2.5 equiv) was added. The resulting solution was 
warmed to reflux (using an oil bath preheated to 80°C) and stirred for 2 to 8 hours until 
the diol was completely consumed (TLC). The reaction was quenched with a saturated 
solution ofNH4CI (5 mL) and the mixture was extracted with CH2Cb (3 x 50 mL). The 
combined organic layers were then washed with water (50 mL), dried over Na2S04 and 
concentrated. The resultant yellow oil was purified by flash column chromatography 
(silica gel) using an appropriate solvent system. 
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319 
Methyl cis-tetrahydro-3H-1,2,3-benzoxathiazole-3-carboxylate 2,2-dioxide (319) 
Eluent: hexanes-ethyl acetate, 4:1; Rj 0.42 (2:1 Hex:EtOAc); mp 145-147 °C (EtOAc); 
IH NMR (CDCh, 600 MHz) 8 6.12 (m, IH), 5.81 (d, J= 10.32 Hz, IH), 5.21 (s, IH), 4.80 
(s, IH), 3.93 (s, 3H), 2.35 (m, IH), 2.30 (m, IH), 2.15 (m, IH), 1.92 (m, IH) ppm; l3C 
NMR (CDCh, 150 MHz) 8 150.5, 131.6, 120.7, 77.8, 55.5, 54.6, 24.0, 18.5 ppm; IR 
(KBr) v 3438.9, 3010.2, 2963.5, 2853.3, 2544.9, 1725.9 em-I; LRMS (FAB+NBA 
matrix) mlz 234, 214 (13.5), 156 (27.4), 79 (40.3); HRMS calcd. for CsH12N04S 
234.0436, found: 234.0394. Anal. calcd for CsHuN05S: C 41.20, H 4.75. Found: C 
41.32, H 4.75. 
322 
Bis-«lR,2S,SR)-2-isopropyl-S-methylcyclohexyl) 1-phenylethane-1,2-diyldicarba-
mate (322) 
RjO.75 (1:1 Hex:EtOAc); mp 173-175 °C (EtOAc); IH NMR (CDCh, 300 MHz) 8 7.36 
(m, 2H), 7.29 (m, 3H), 5.72 (m, IH), 4.82 (m, 2H), 4.56 (m, 2H), 3.52 (s, 2H), 2.01 (m, 
4H), 1.69 (m, 5H), 1.51 (s, 3H), 1.32 (m, 2H) 0.95 (m, 24H); l3C NMR (CDCh, 150 
MHz) 8 128.7, 127.7, 126.3,.75.0, 74.8, 56.4, 47.3, 41.4, 34.3, 31.4, 26.3, 23.5, 22.0, 
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20.9, 16.4; IR (KBr) v 1015.2, 1148.8, 1291.1, 1455.0, 1533.1, 1685.8, 2956.1, 3364.2 
em-I; LRMS (FAB+NBA matrix) mlz, 501(11.3), 319 (22.1), 225 (24.3), 181 (69.9), 120 
(38.0),83 (100.0); Anal. ealed for C30H48N204: C 71.96, H 9.66, N 5.59, found: C 71.70, 
H 9.78, N 5.60. 
2,2,2, Triflooroethyl cis-hexahydro-3H-l,2,3-benzoxathiazole-3-carboxylate 2,2-
dioxide (323) 
Eluent: hexanes-ethyl acetate, 2:1; Rf 0.45 (2:1 Hex:EtOAe); mp 83-85 DC (EtOAe); IH 
NMR (CDCh, 600 MHz) 5 5.07 (d, J= 3.1 Hz, IH), 4.69 (m, IH), 4.61 (m, IH), 4.27 (m, 
IH), 2.38 (m, IH), 2.33 (m, IH), 1.90 (m, IH), 1.81 (m,2H), 1.69 (m, IH), 1.55 (m, IH), 
1.27 (m, IH); BC NMR (CDCh, 150 MHz) 5 148.3, 122.3 (q, J= 278.8 Hz), 80.0, 62.5 
(q, J = 37.6 Hz), 58.4, 26.9, 21.8, 18.8; IR (KBr) v 3031.7, 2947.2, 2871.5, 1755.5, 
1623.1 em-I; LRMS (FAB+NBA matrix) mlz 304,258 (5.5),224 (43.3), 136 (30.7), 81 
(100.0); HRMS ealed. for C9HI3F3N05S: 304.0512, found: 304.0467; Anal. ealed for 
C9H I2F3N05'S: C 35.65, H 3.99, found: C 35.74, H 3.98. 
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2,2,2-Trlfluoroethyl cis-tetrahydro-3H-l,2,3-benzoxathiazole-3-carboxylate 2,2-
dioxide (324) 
Eluent: hexane8-ethyl acetate, 2: 1; Rj 0.46 (2: 1 Hex: EtOAc ); mp 70-72 DC (EtOAc); IH 
NMR (CDCh, 300 MHz) 8 6.15 (m, IH), 5.79 (d, J= 10.2 Hz, IH), 5.24 (8, IH), 4.85 (8, 
IH), 4.65 (m, 2H), 2.29 (m, 2H), 2.09 (m, IH), 1.85 (m, IH); 13C NMR (CDCh, 75 MHz) 
8 148.6, 132.3, 122.3 (q, J= 277.7 Hz), 120.1, 78.1, 62.5 (q, J= 37.6 Hz), 55.7, 27.1, 23.9, 
18.5; IR (KBr) v 3492.1, 3044.8,2982.3, 2933.8,2853.8, 1766.9 cm-I; LRMS (EI) mlz 
301, 221 (33.5),220 (18.4), 216 (14.2), 120 (21.5), 94 (30.0), 78 (100.0); HRMS calcd. 
for C9HlOF3NOsS: 301.0232, found: 301.0229; Anal. calcd for C9HlOF3NOsS: C 35.88, H 
3.35, found: C 35.98, H 3.24. 
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5.3 Stability studies 
NMR data collection protocol 
The Be NMR spectra were acquired on a Broker Avance AV600 spectrometer equipped 
with a BBO-Z grad probe and VT accessory. A series of Be NMR spectra were recorded 
for each reagent using a power gated proton decoupling pulse sequence from the Bruker 
library with a 30 degree flip angle and a 2 s relaxation delay. Each spectrum was acquired 
using 256 transients, 16K data points with a spectral width of238 ppm, a line broadening 
of 1Hz and zero filled to 32K points. The acquisition time for each spectrum was 11 
minutes. All spectra were processed and analyzed using Broker Topspin2.1 PL4 software 
running on a Windows XP workstation. 
Decomposition study of Burgess reagents at 50°C 
100 mg of Burgess reagent was dissolved in 0.75 mL d8_ THF in an NMR tube. Be 
proton decoupled spectra were acquired at 12 minute intervals on the 600 MHz 
spectrometer. The integral of the carbonyl peak was compared to that of the solvent peak 
at 64.6 ppm to determine the percentage of reagent remaining in each spectrum. 
Decomposition study of Burgess reagents at 78°C 
Six identical reactions were set up in microreactor vials. 100 mg of Burgess reagent was 
dissolved in 0.75 mL d8_ THF. The reaction vials were placed in a pre-heated 
microreactor block. At 12 minute intervals, one vial was removed, cooled in liquid 
nitrogen and transferred to a dried NMR tube and a Be proton decoupled NMR spectrum 
was acquired. The percentage of intact Burgess reagent remaining was determined by 
comparing the integral of the carbonyl peak to that of the solvent peak at 64.6 ppm. 
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5.4 Intermediates in morphine synthesis 
B 0 c:(~NHBOC 
OTDS 
11 
A solution of Boc-glycine (12.0 g, 70 mmol), DCC (18.5 g, 90 mmol) and DMAP (85 
mg, 7 mmol) in DCM (200 mL) was cooled to 0 °C and a solution of TDS protected diol 
329 (15.0 g, 45 mmol) in DCM (200 mL) was added slowly over a period of 10 min. The 
reaction mixture was stirred for 14 hours warming to rt. The solution was diluted with 
Et20 (200 mL) and filtered through a plug of silica to remove dicyclohexyl urea. The 
solvent was removed under reduced pressure and chromatographed on silica gel with 
hexanes:ethyl acetate 9: 1 as the eluent. The product 11 was isolated as a colorless oil 
(15.4 g, 31.5 mmol, 70 %). Rf 0.7 (4:1 Hex:EtOAc); [a]D20 -64.0 (c = 1.0, MeOH); IH 
NMR CDCh, 300 MHz) 8 6.27 (dd, J= 5.2, 3.1 Hz, IH), 5.59 (d, J= 3.9 Hz, 1H), 5.00 
(bs, 1H), 3.97 (m, 3H), 2.39-2.19 (m, IH), 2.15-2.09 (m, IH), 1.85-1.62 (m, 2H), 1.43 (s, 
9H), 0.84 (s, 3H), 0.82 (s, 3H), 0.77 (d, J = 1.9 Hz, 6H), 0.07 (d, J = 4.6 Hz, 6H) ppm; 
13C NMR (CDCh, 75 MHz) 8 169.6, 155.3, 134.8, 117.0, 79.6, 73.9, 69.2, 42.3, 34.0, 
28.2, 25.5, 24.7, 22.6, 20.0, 18.5, -3.1, -3.15 ppm; IR (film) v 3445, 2958, 1755, 1715, 
1511 cm-I; LRMS (EI) mlz 171 (7), 157 (9), 136 (34), 121 (9), 79 (10), 28 (100); HRMS 
calcd. for C2IH39NSiBrOs(M+H): 492.1781, found: 492.1806; Anal. calcd. for 
C2IH3SNSiBrOs: C 51.21, H 7.78, found: C 51.41, H 7.75. 
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Br C02Me ,~NHBOC 
TDSO"V 
10 
Glycine ester 11 (6g, 11.8 mmol) was dissolved in THF (100 mL). A solution ofZnCh in 
THF (1.0 M, 19 mL, 19.0 mmol) was added and the mixture was cooled to -78°C. A 
solution ofLDA (2.2 M, 8.6 mL, 19.0 mmol) in THF was added dropwise. The reaction 
was stirred for 16 hours warming to room temperature. The reaction mixture was then 
acidified to a pH of approximately 2.5 with 1M HCI. The resulting solution was then 
extracted with Et20 (3 x 100 mL), washed with brine (20 mL), and dried over Na2S04. 
The solvent was removed under reduced pressure to give amino acid 330 as a mixture of 
diastereomers. The unpurified acid was then treated with excess diazomethane. The 
resulting diastereomeric mixture of esters 10 was then chromatographed on silica gel with 
hexanes:ethyl acetate 20: 1 to give enantiopure esters 9 and 321 in a ratio of 1:4 with a 
combined yield of 68 % over 2 steps. 
Br C02Me ~NHBOC 
TDSoN 
9 
Yield 3.25 g (1.6 mmol); Rf 0.65 (4:1 Hex:EtOAc); [a]n20 -27.7 (c = 1.0, CHCL3); IH 
NMR (CDCh, 300 MHz) 8 6.27 (dd, J= 5.6, 1.3 Hz, IH), 4.81 (m, 2H), 4.12 (m, IH), 
4.11 (m, IH), 3.71 (s, 3H), 2.96 (bs, IH), 1.86-1.76 (m, IH), 1.63-1.50 (m, 3H), 1.40 (s, 
9H), 0.86 (d, J = 6.9 Hz, 6H), 0.80 (s, 6H), 0.06 (d, J = 5.3 Hz, 6H) ppm; BC NMR 
(CDCb, 75 MHz) 8 171.7, 155.4, 135.5, 127.9, 79.7, 65.4, 55.2, 52.2, 43.7, 34.1, 29.5, 
28.2,24.8,20.2, 19.9, 18.5, -2.6, -3.0 ppm; lR (KEr) v 3443,2956,2868, 1749, 1715 cm-
I; LRMS (El) mlz 370 (13), 366 (38), 364 (37), 348 (16), 346 (15),231 (24),229 (24), 
- 93-
162 (95), 75 (100); HRMS calcd. for C22H4INSiBr05(M+H): 506.1920, found: 
506.1937; Anal. calcd. for C22H4oNSiBr05: C 52.16, 7.96, found: C 52.34, 8.0l. 
Br C02Me 
N"'NHBOC 
TDsoN 
331 
Yield 13.0 g (6.4 mmol); Rf 0.7 (4:1 Hex:EtOAc); [a]D20 -55.7 (c = 1.0, CHCL3); IH 
NMR (CDCh, 300 MHz) 0 6.30 (dd, J = 5.6, l.3 Hz, 1H), 5.21 (d, J = 8.6 Hz, 1H), 4.68 
(dd, J = 8.7, 2.3 Hz, 1H), 4.11 (m, 1H), 3.71 (s, 3H), 3.05 (bs, 1H), 1.86-1.78 (m,2H), 
1.63-1.50 (m, 2H), 1.43 (s, 9H), 0.84 (d, J= 6.9 Hz, 6H), 0.80 (s, 6H), 0.05 (d, J= 5.3 
Hz, 6H) ppm; l3C NMR (CDCh, 75 MHz) 0 171.9, 155.4, 136.3, 125.5, 80.0, 66.7, 55.9, 
52.3,45.1,34.2,29.2,28.3,25.8,24.7,23.4,20.2, 18.6, -2.7, -2.9 ppm; IR (KBr) v 3439, 
2955,2867, 1753, 1720 cm-I; HRMS calcd. for C22~INSiBr05(M+H): 506.1920, found: 
506.1937; Anal. calcd. for C22~oNSiBr05: C 52.16, 7.96, found: C 52.28, 8.06. 
Procedure for recycling 331 to diastereomeric mixture 10. 
The undesired diastereomer of the C-ring fragment 331 (13.0 g, 6.4 mmol) was dissolved 
in DME (50 mL). DBU (0.49 g, 3.2 mmol) was added and the solution was brought to 
reflux and was stirred at reflux for 3 days. The mixture was then diluted with Et20 (100 
mL) and washed with a 10 % citric acid solution to remove DBU, washed with brine (2 x 
20 mL) and dried over Na2S04. The solvent was removed under reduced pressure to give 
diastereomeric mixture 10. The mixture was then chromatographed as described above to 
give 9 and 331 (1: 1 ratio) in 80 % combined yield. 
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/0 
'0 
TDSO'\' 
NHBoc 
7 
To a flame-dried flask containing Pd(dppf)2Clz (104 mg, 0.090 mmol) was added methyl 
ester 9 (456.4 mg, 0.901 mmol) in degassed THF (7 mL). Boronic acid 8 (328 mg, l.802 
mmol) was then added, along with CS2C03 (89 mg, 0.270 mmol). The resulting mixture 
was then stirred at reflux overnight. The reaction mixture was then filtered through a plug 
of silica with EtOAc, and concentrated to give 569 mg of brown oil. The oil was then 
chromatographed on Si02 using 4:1 hexanes : ethyl acetate as the eluent. The coupled 
product 7 (448 mg, 0.794 mmol, 88%) was obtained as a clear and colorless oil. Rf 0.8 
(1:1 Hex:EtOAc); IH NMR (300 MHz, CDCh) 8 6.97 (t, J= 7.91 Hz, IH), 6.82 (dd, J= 
8.29, l.1 Hz, IH), 6.66 (d, J = 7.65 Hz, IH), 5.77 (dd, J = 3.93, l.54 Hz, IH), 5.71 (d, J 
= 9.72 Hz, IH), 4.33 (dd, J = 9.72, 2.28 Hz, IH), 4.24 (m, IH), 3.85 (s, 6H), 3.23 (s, 
IH), 1.74 (m, 2H), 1.74 (q, J = 6.86 Hz, IH), 1.55 (bs, 4H), 1.42 (s, 9H), 0.91 (dd, J = 
6.84,0.93 Hz, 6H), 0.85 (s, 7H), 0.10 (s, 6H) ppm; BC NMR (CDCh, 75 MHz) 8 172.6, 
155.2,152.3, 146.2, 139.5, 134.6, 132.5, 124.1, 122.0, 11l.8, 79.3, 63.4, 60.6, 55.7, 54.7, 
52.1,38.4,34.4,30.1,28.4,24.9,20.5, 18.7, 17.9, -2.3, -2.8 ppm; IR (neat) v 3449,3019, 
2956,2401, 1748, 1716 cm-I; LRMS (FAB + NBA matrix) mlz 404 (10.0), 375 (17.1), 
287 (68.2), 227 (54.9); HRMS calcd. for C30H49N07Si: 506.2574, found: 506.2538. 
/0 
'0 
336 
NHBoc 
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To a stirred solution ofsilyl ether 7 (448 mg, 0.794 mmol) in distilled THF (10mL) was 
added tetra-n-butylammonium fluoride (0.87 mL, 0.873 mmol, 1M solution in THF) 
dropwise at 0 °C. The resulting solution was allowed to warm to r.t. and stir for 20 hrs. 
The reaction was diluted with distilled water (20 mL) and THF was removed under 
reduced pressure. The aqueous residue was then extracted with ethyl acetate (3x 10 mL). 
The combined organic layers were rinsed with distilled water (10 mL), brine (10 mL) and 
dried over sodium sulfate. The resulting mixture was filtered and concentrated to give 
free alcohol 336 (271 mg, 0.644 mmol, 81%) as a colorless oil. RI 0.3 (1:1 Hex:EtOAc); 
[a]n20 34.65 (c = 0.2, CHCh); IH NMR (CDCh, 300 MHz) 0 6.98 (t, J = 7.9 Hz, 1H), 
6.83 (dd, J = 8.2, 1.4 Hz, 1H), 6.68 (d, J = 7.5 Hz, 1H), 5.89 (dd, J = 3.9, 1.40 Hz, 1H), 
5.56 (d, J = 9.7 Hz, IH), 4.3 (dd, J = 9.7, 2.5 Hz, IH), 4.28 (m, IH), 3.86 (s, 3H), 3.84 
(s, 3H), 3.47 (q, J = 7.03, IH), 3.37 (bs, IH), 3.30 (s, 3H), 1.92 (m, 4H), 1.42 (s, 9H) 
ppm; 13C NMR (CDCh, 75 MHz) 0 172.7, 155.2, 152.2, 146.1, 141.7, 134.4, 131.0, 
124.0, 122.1, 112.0, 76.6, 63.5, 60.6, 55.8, 54.9, 52.1, 39.1, 30.0, 28.3, 18.8 ppm; IR 
(neat) v 3354,3015,2938, 1709, 1523 em-I; LRMS (EI) mlz 303 (13.4),216 (100.0), 200 
(24.3), 185 (8.7); HRMS calcd.for C22H31N07: 421.2101, found: 421.2077. Anal. calcd 
for C22H31N07: C 62.69, H 7.41, found: C 62.65, H 7.46. 
NHBoc 
BzO 
337 
To a stirred solution of alcohol 336 and benzoic acid in dry THF was added a solution of 
the Mitsunobu reagent, prepared by the addition of diethyl azodicarboxylate (DEAD) to 
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PBU3 in THF at 0 °c. The reaction mixture was allowed to warm to room temperature 
over three hours and stirred for another three hours. The solvent was removed under 
reduced pressure and the resulting oil was chromatographed on silica gel (Hex: EtOAc 
4: 1). The pure product slowly solidified overnight in the freezer and was recrystallized 
from EtOAc. Rj 0.27 (2:1 Hex:EtOAc); mp 102-105 °c (EtOAc); IH NMR (CDCb, 300 
MHz) 8 8.02 (d, J=7.2 Hz, 2H), 7.54 (t, J=7.4 Hz, IH), 7.42 (t, J= 5.6 Hz, 2H), 6.98 (t, 
J= 7.9 Hz, 1H), 6.83 (dd, J= 1.5, 8.01 Hz, IH) 6.70 (dd, J= 1.1, 7.2 Hz, 1H) 5.9 (s, 1H) 
3.87 (s, 3H), 3.86 (s, 3H), 3.53 (s, IH), 3.26 (s, 3H), 2.22 (m, 2H), 1.86 (m, 2H), 1.55 (s, 
2H), 1.45 (s, 9H) ppm; BC NMR (CDCh, 150 MHz) 8: 171.8, 166.3, 156.2, 152.8, 146.2, 
139.2, 135.1, 133.0, 129.7, 128.4, 123.8, 122.2, 112.1,61.4, 56.0, 51.8,40.9,28.5,26.9, 
24.8 ppm; LRMS (EI) mlz 525, 403 (8.4), 303 (20.8), 260 (50.4), 216 (100); HRMS 
calcd. for C29H3SNOs: 525.2363, found: 525.2369 . 
......... 0 
'0 
HO 
339 
To a stirred solution of benzoyl ester 337 (148 mg, 0.282 mmol) in distilled DCM (1 mL) 
was added distilled TFA (0.25 mL) at r.t. The reaction was allowed to stir for 24 hr. and 
was then diluted with DCM (10 mL) and washed with NaHC03 (2 x 3 mL). The aqueous 
layer was extracted with DCM (1 x 5 mL). Combined organic layers were rinsed with 
distilled water (5 mL) and brine (5 mL) and dried over Na2S04. The organic layer was 
then filtered and concentrated to give a yellow oil. The crude mixture was purified by 
FCC (98:2 DCM:MeOH) to give 339 as a clear oil (33 mg, 0.103 mmol, 36%). 
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RfO.3 (95:5 DCM:MeOH), [a]D20= 128.1 (c=0.29, CHCh, 95% CI); IH NMR (300 MHz, 
CDCh) 8: 6.96 (t, J=7.94 Hz, IH), 6.81 (d, J= 7.23 Hz, IH), 6.65 (d, J= 7.53 Hz, IH), 
6.58 (d, J=5.13 Hz, IH), 3.85 (s, 3H), 3.73 (s, 4H), 3.46 (s, 3H), 3.40 (s, IH), 3.40 (s, 
IH), 2.30 (s, IH), 2.01 (m, IH), 1.82 (m, IH), 1.69 (m, IH), 1.41 (m, IH), 1.25 (s, IH), 
0.86 (m, IH) ppm; l3C NMR (150 MHz, CDCh) 8: 152.9, 146.8, 138.7, 134.4, 132.6, 
124.0, 121.0, 111.6, 60.5, 58.5, 55.9, 52.1, 47.1, 38.8, 26.4, 23.1, 21.2, 14.3 ppm; mlz 
(EI) 303 (M - H20, 21.2) 272 (9.5) 244 (7.4) 216 (100) HRMS calcd for C17H23N05: 
303.1471 (M+ -H20); found 303.1469 (M+ -H20) 
OH 
NHBoc 
341 
Diester 337 (0.848 g, 1.6 mmol) was dissolved in 10 mL dry THF and cooled in an 
ice/water bath~ Lithium aluminum hydride (0.153 g, 4.0 mmol) was added in one portion. 
The mixture was stirred for 2 hours warming to room temperature. The reaction was 
quenched by successively adding 0.15 mL water, 0.30 mL NaOH (15%), and 0.45 mL 
water. The aluminum salts were filtered off and the resulting oil was concentrated and 
chromatographed (1:2 Hex:EtOAc) yielding alcohol 341 (0.586 g, 1.5 mmol, 94 %) as a 
thick colorless oil. Rf0.26 (1:2 Hex:EtOAc); [a]2oD 86.91 (MeOH); IH NMR (DMSO tf, 
600 MHz) 8 6.89 (s, 2H), 6.54 (dd, J = 604, 1.8 Hz, IH), 6.00 (d, J = 8.7 Hz, IH), 5.56 (s, 
IH), 4.70 (d, J = 5.3 Hz, IH), 4.54 (t, J = 5.4 Hz, IH), 4.18 (d, J = 3.7 Hz, IH), 3.78 (s, 
3H), 3.68 (s, 3H), 3.16 (m, 4H), 1.97 (m, IH), 1.74 (m, IH), 1.32 (s, 9H), 1.12 (s, 2H) 
ppm; l3C NMR (DMSO tf, 150 MHz) 8 155.5, 152.1, 146.0, 139.9, 136.6,.135.4, 124.0, 
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122.3, 111.7, 77.7, 66.0, 61.5, 60.2, 56.0, 53.0, 37.1, 32.0, 28.7, 20.2 ppm; IR (film) v 
3384,2938, 1696, 1577, 1472 cm-\ LRMS (EI) mlz 375 (m- H20), 321 (5.5),264 (20.2), 
244 (14.9), 216 (100.0); HRMS calcd. for C2IH29NOs: 375.2046, found: 375.2039. Anal. 
calcd. for C2IH3IN06 C 64.10, H 7.94, found: C 63.83, H 8.24. 
/0 
'0 0 )=0 
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H 
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6 
To a solution of alcohol 341 (0.311 g, 0.79 mmol) in THF (10 mL) was added NaH 
(0.019 g, 0.79 mmol). The mixture was stirred at room temperature for 10 hours. The 
reaction was quenched with citric acid solution (10 % w/w, 5 mL). The aqueous phase 
was separated and extracted with ether (2x20 mL). The crude material (271 mg) was 
chromatographed on Si02 and chromatographed with 1: 1 hexanes/ethyl acetate as the 
eluent. The product 6 (0.201 g, 0.63 mmol, 80 %) was isolated as a colorless oil. 
RjO.2 (1:2 Hex:EtOAc); IH NMR (CDCh, 300 MHz) 0: 7.06 (t, J= 7.92 Hz, IH), 6.89 
(d, J= 8.22 Hz, IH), 6.67 (dd, J= 7.65,1.17 Hz, IH), 5.87 (m, IH), 4.41 (m, IH), 4.16 
(m, IH), 3.89 (s, 3H), 3.82 (s, 3H), 3.55 (t, J= 4.74 Hz, IH), 2.76 (bs, IH), 2.27 (m, IH), 
1.67 (m, IH), 1.59 (m, IH), 1.40 (m, IH) ppm. BC NMR (CDCh, 75 MHz) 0 159.3, 
152.9, 145.7, 134.7, 124.8, 121.0, 111.7, 71.6, 71.1, 67.3, 67.0, 61.9, 61.4, 55.8, 53.3, 
42.1, 31.7, 31.2, 19.3, 14.2 ppm; IR (neat) v 3368,2936, 1747, 1576 cm-I; LRMS (EI) 
mlz 301 (3.9),216 (49.1), 200 (14.1), 87 (87.3); HRMS calcd. for C17H2INOs: 301.1314, 
found: 301.1310. 
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5.5 Biotransformations 
General procedure for small scale fermentation with E. coli JMI09(pDTG601) 
Growth of colonies. 
Agar plates consisted ofbactotryptone (10 giL), yeast extract (5 gIL), NaCl (5 gIL), agar 
(30 giL), and ampicillin (100 mglL). E. coli JM109(pDTG60l) cells were streaked onto a 
plate and incubated at 35 DC for 24 hours. A single colony was isolated for the preculture 
preparations described in the following section. 
Preculture. 
Luria Bertani (LB) media consisted ofbactotryptone (10 gIL), yeast extract (5 gIL), NaCl 
(5 giL), and ampicillin (100 mg/L). Three mL ofLB media was inoculated with a single 
colony of E. coli JM 1 09 (pDTG60 1) and grown at 35 DC in an orbital shaker. 
Fernbach shake flask. 
Luria Bertani (LB) media consisted ofbactotryptone (10 gIL), yeast extract (5 gIL), NaCl 
(5 giL), and ampicillin (100 mglL). A 3 L Fernbach shake flask was charged with 500 
mL LB media and then inoculated with 1 mL of E. coli JMl09(pDTG60l) preculture 
media. The inoculum was grown for 12 hours at 35 DC in an orbital shaker. The contents 
of the shake flask were added to a 15 L Sartorius Biostat C fermentor and grown 
according to literature procedure for 24 hours. 156 
Substrate addition 
500 mL of cell broth was- drained from the fermentor and the cells were separated by 
centrifugation. The supernatant was drained off and the cells were re-suspended in 500 
mL phosphate buffer (0.1 M) containing 2 gIL glucose. The substrate (200-400 gIL) was 
- 100-
added neat or as a solution in isopropanol. Product formation was monitored by TLC 
(hexane/EtOAc, 1: 1). 
Product isolation 
After 5 hours of incubation, the pH of the media was adjusted to 8.5 with NaOH (1 M) 
and the supernatant was separated from the cells by centrifugation. The supernatant was 
then extracted with EtOAc (3x500 mL). The extract was washed with saturated Na2C03 
(100 mL) and brine (100 mL) and dried over anhydrous Na2S04. Ethyl acetate was 
removed under reduced pressure and the crude material was purified by crystallization 
(EtOAc/pentane) or flash colum chromatography. 
Large scale fermentations 
Large scale fermentations were performed according to literature procedure. 156 
methyl 2-fluoro-5,6-dihydroxycyclohexa-l,3-dienecarboxylate (344): 
Rf 0.15 (1:1 Hex:EtOAc); mp 74-76 °C (EtOAc); [at2o = +73.2 (c 1.05, MeOH); IH 
NMR (CDCh, 600 MHz) 8 6.33 (m, IH), 5.94 (ddd, J = 10.2, 8.3,2.6 Hz, IH), 4.71 (t, J 
= 6.2 Hz, IH), 4.55 (m, IH), 3.83 (s, 3H), 3.17 (bs, IH), 3.09 (brs, IH) ppm; l3C NMR 
(CDCh, 150 MHz) 8 166.0 (d, J = 2.2 Hz), 163.2 (d, J = 281.0 Hz), 143.1 (d, J = 12.1 
Hz), 119.6 (d, J = 36.2 Hz), 106.2 (d, J = 2.2 Hz), 69.0, 67.0 (d, J = 6.6 Hz), 52.2 ppm; 
I9F NMR (CDCh, 282 MHz) 8 -92.6 (s) ppm; IR (film) 3558, 3025, 1694, 1439, 1401, 
1040 cm-I; LRMS (EI) mlz 188 (15), 133 (44), 119 (49), 102 (100), 91 (37),90 (46), 86 
(28), 74 (16), 46 (27); HRMS calcd. for CgH9F04 (Ml: 188.0485, found: 188.0484; 
Anal. calcd. for CgH9F04: C, 51.07; H, 4.82, found: C, 51.18; H, 4.76. 
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C02Me CI~OH 
UOH 
348 
methyl 2-chloro-5,6-dihydroxycyclohexa-l,3-dienecarboxylate (348): 
Rf 0.25 (1:1 Hex:EtOAe); mp 107-109 °c (EtOAe); [a]D20 = +86.6 (e 1.0, CHCh); IH 
NMR (CDCh, 600 MHz) () 6.35 (d, J= 9.8 Hz, IH), 6.03 (dd, J= 9.8,3.0 Hz, IH), 4.44 
(m, IH), 4.31 (d,J= 6.0 Hz, IH), 3.83 (s, 3H), 2.50 (bs, 2H) ppm; BC NMR (CDCh, 150 
MHz) () 164.8, 140.5, 127.8, 125.1, 124.0, 72.5, 67.4, 52.3 ppm; IR (KBr) 3422, 2959, 
1721, 1578, 1444, 1270, 758 em-I; LRMS (EI) mlz [M-H20t: 188 (15), 186 (43), 157 
(32), 155 (100), 99 (14); HRMS ealed. for CsH9CI04 [M-H20t 188.0084, found: 
188.0077. 
CI 
Me02C~OH 
UOH 
349 
methyl 2-chloro-3,4-dihydroxycyclohexa-l,5-dienecarboxylate (349): 
Rf 0.18 (1:1 Hex:EtOAe); mp 107-109 °c (pentane-,-ethyl acetate); [a]D 20 = +36.9 (e 1.0, 
CHCh); IH NMR (CDCh, 300 MHz) () 6.18 (ddd, J= 10.0,2.4, 1.2 Hz, IH), 6.01 (dd, J 
= 10.0, 2.4 Hz, IH), 4.64 (ddd, J = 6.0, 4.7, 1.2 Hz, IH), 4.52 (ddt, J = 8.7, 6.0, 2.4 Hz, 
IH), 3.86 (s, 3H), 2.76 (d, J = 9.6 Hz, IH), 2.60 (d, J = 4.7 Hz, IH) ppm; BC NMR 
(CDCh, 150 MHz) () 166.3, 138.8, 138.5, 127.5, 123.8, 68.6, 67.7, 52.3 ppm; IR (KBr) 
3398, 3459, 1698, 1317, 1057, 762 em-I; LRMS (EI) mlz: 204 (14), 173 (23), 172 (54), 
155 (50), 146 (32), 145 (36), 144 (100), 143 (80), 139 (27), 99 (27), 81 (41),53 (25),51 
(21); HRMS ealcd. for CsH9CI04: 204.0189, found: 204. 0190. 
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C02Me Br~OH 
U OH 
352 
methyl 2-bromo-5,6-dihydroxycyclohexa-l,3-dienecarboxylate (352): 
Rf 0.18 (1:1 Hex:EtOAe); mp 106-109 °c (CHCh); IH NMR (CDCh, 600 MHz) 8 6.17 
(dd, J = 10.0, 2.5 Hz, IH), 6.04 (ddd, J = 10.0, 2.5, 1.3 Hz, IH), 4.57 (m, IH), 4.49 (m, 
IH), 3.85 (s, 3H), 3.00 (d, J = 7.9 Hz, IH), 2.97 (bs, IH) ppm; I3C NMR (CDCh, 150 
MHz) 8 166.6, 137.5, 130.0, 128.0, 127.3, 68.4, 68.1, 52.3 ppm; IR (KBr) 3402, 1703, 
1437, 1314, 1234, 1048 em-I; LRMS mlz: 248 (9), 218 (38),216 (47), 190 (82), 189 (53), 
188 (85), 187 (48), 109 (71), 108 (31), 81 (100),65 (79), 59 (45), 53 (54); HRMS ealed. 
for CSH9Br04: 247.9684, found: 247.9679. 
methyl 3,4-dihydroxy-2-iodocyclohexa-l,5-dienecarboxylate (356): 
IH NMR (600 MHz, CDCh) 8 6.19 (d, J= 9.8 Hz, IH), 6.11 (dd, J= 9.8, 3.8 Hz, IH), 
4.42 (m, IH), 4.36 (t, J= 6.6 Hz, IH), 3.83 (s, 3H), 3.12 (brd, J= 7.6 Hz, IH), 2.59 (brd, 
J = 7.2 Hz, IH) ppm; BC NMR (151 MHz, CDCb) 8 166.0, 134.3, 129.3, 123.9, 111.20, 
67.2, 52.4 ppm; LRMS I: 296 (12), 278 (83), 264 (38), 247 (90), 231 (31), 137 (100), 109 
(95), 92 (43), 81 (89), 63 (35), 59 (38), 53 (62); HRMS ealed for CsH9I04: 295.9546, 
found: 295.9538. 
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